PRJNA375882: Comprehensive Mouse Transcriptomic BodyMap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Tfdp1
|
ENSMUSG00000038482.12 | Tfdp1 |
Wt1
|
ENSMUSG00000016458.16 | Wt1 |
Egr2
|
ENSMUSG00000037868.16 | Egr2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Egr2 | mm39_v1_chr10_+_67373691_67373760 | 0.62 | 5.3e-09 | Click! |
Tfdp1 | mm39_v1_chr8_+_13389656_13389674 | 0.45 | 6.5e-05 | Click! |
Wt1 | mm39_v1_chr2_+_104961228_104961326 | -0.12 | 3.2e-01 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr16_-_18448614 | 41.33 |
ENSMUST00000231956.2
ENSMUST00000096987.7 |
Septin5
|
septin 5 |
chr15_+_83664196 | 38.01 |
ENSMUST00000046168.12
|
Mpped1
|
metallophosphoesterase domain containing 1 |
chr16_-_18448454 | 34.64 |
ENSMUST00000231622.2
|
Septin5
|
septin 5 |
chr2_+_28095660 | 32.26 |
ENSMUST00000102879.4
ENSMUST00000028177.11 |
Olfm1
|
olfactomedin 1 |
chr11_+_7013422 | 32.13 |
ENSMUST00000020706.5
|
Adcy1
|
adenylate cyclase 1 |
chr11_-_6015538 | 30.15 |
ENSMUST00000101585.10
ENSMUST00000066431.14 ENSMUST00000109815.9 ENSMUST00000109812.9 ENSMUST00000101586.3 ENSMUST00000093355.12 ENSMUST00000019133.11 |
Camk2b
|
calcium/calmodulin-dependent protein kinase II, beta |
chr15_+_83664175 | 29.53 |
ENSMUST00000163723.8
|
Mpped1
|
metallophosphoesterase domain containing 1 |
chr8_-_125161061 | 29.17 |
ENSMUST00000140012.8
|
Pgbd5
|
piggyBac transposable element derived 5 |
chr15_-_66158445 | 28.31 |
ENSMUST00000070256.9
|
Kcnq3
|
potassium voltage-gated channel, subfamily Q, member 3 |
chr4_+_127062924 | 27.64 |
ENSMUST00000046659.14
|
Dlgap3
|
DLG associated protein 3 |
chr2_-_32737238 | 27.64 |
ENSMUST00000050000.16
|
Stxbp1
|
syntaxin binding protein 1 |
chr10_+_79552421 | 27.17 |
ENSMUST00000099513.8
ENSMUST00000020581.3 |
Hcn2
|
hyperpolarization-activated, cyclic nucleotide-gated K+ 2 |
chr12_+_108300599 | 27.10 |
ENSMUST00000021684.6
|
Cyp46a1
|
cytochrome P450, family 46, subfamily a, polypeptide 1 |
chrX_-_72703330 | 26.65 |
ENSMUST00000114473.8
ENSMUST00000002087.14 |
Pnck
|
pregnancy upregulated non-ubiquitously expressed CaM kinase |
chr4_+_129878890 | 26.15 |
ENSMUST00000106017.8
ENSMUST00000121049.8 |
Adgrb2
|
adhesion G protein-coupled receptor B2 |
chr10_-_127099183 | 25.87 |
ENSMUST00000099172.5
|
Kif5a
|
kinesin family member 5A |
chr13_-_69147639 | 25.49 |
ENSMUST00000022013.8
|
Adcy2
|
adenylate cyclase 2 |
chr4_+_129878627 | 25.24 |
ENSMUST00000120204.8
|
Adgrb2
|
adhesion G protein-coupled receptor B2 |
chr4_+_42917228 | 25.11 |
ENSMUST00000107976.9
ENSMUST00000069184.9 |
Phf24
|
PHD finger protein 24 |
chr2_-_180776920 | 24.98 |
ENSMUST00000197015.5
ENSMUST00000103050.10 ENSMUST00000081528.13 ENSMUST00000049792.15 ENSMUST00000103048.10 ENSMUST00000103047.10 ENSMUST00000149964.9 |
Kcnq2
|
potassium voltage-gated channel, subfamily Q, member 2 |
chr2_-_32737208 | 24.73 |
ENSMUST00000077458.7
ENSMUST00000208840.2 |
Stxbp1
|
syntaxin binding protein 1 |
chr11_-_6015736 | 24.03 |
ENSMUST00000002817.12
ENSMUST00000109813.9 ENSMUST00000090443.10 |
Camk2b
|
calcium/calmodulin-dependent protein kinase II, beta |
chr15_+_74435587 | 23.73 |
ENSMUST00000185682.7
ENSMUST00000170845.8 ENSMUST00000187599.2 |
Adgrb1
|
adhesion G protein-coupled receptor B1 |
chr17_+_24707711 | 23.54 |
ENSMUST00000024958.9
ENSMUST00000234717.2 |
Caskin1
|
CASK interacting protein 1 |
chrX_-_20787150 | 23.39 |
ENSMUST00000081893.7
ENSMUST00000115345.8 |
Syn1
|
synapsin I |
chr15_+_88943916 | 23.39 |
ENSMUST00000161372.2
ENSMUST00000162424.2 |
Panx2
|
pannexin 2 |
chr2_-_162502994 | 22.62 |
ENSMUST00000109442.8
ENSMUST00000109445.9 ENSMUST00000109443.8 ENSMUST00000109441.2 |
Ptprt
|
protein tyrosine phosphatase, receptor type, T |
chr9_+_58395850 | 22.59 |
ENSMUST00000085658.5
|
Insyn1
|
inhibitory synaptic factor 1 |
chrX_-_58179754 | 22.26 |
ENSMUST00000033473.12
|
Fgf13
|
fibroblast growth factor 13 |
chr8_+_94537460 | 22.21 |
ENSMUST00000034198.15
ENSMUST00000125716.8 |
Gnao1
|
guanine nucleotide binding protein, alpha O |
chr1_-_33946802 | 22.03 |
ENSMUST00000115161.8
ENSMUST00000129464.8 ENSMUST00000062289.11 |
Bend6
|
BEN domain containing 6 |
chr8_+_96404713 | 22.01 |
ENSMUST00000041318.14
|
Ndrg4
|
N-myc downstream regulated gene 4 |
chr15_+_100768806 | 21.91 |
ENSMUST00000201549.4
ENSMUST00000108908.6 |
Scn8a
|
sodium channel, voltage-gated, type VIII, alpha |
chr7_-_30826184 | 21.72 |
ENSMUST00000211945.2
|
Scn1b
|
sodium channel, voltage-gated, type I, beta |
chr7_-_125681577 | 21.71 |
ENSMUST00000073935.7
|
Gsg1l
|
GSG1-like |
chr7_-_45019984 | 21.63 |
ENSMUST00000003971.10
|
Lin7b
|
lin-7 homolog B (C. elegans) |
chr7_+_4693759 | 21.52 |
ENSMUST00000048248.9
|
Brsk1
|
BR serine/threonine kinase 1 |
chr13_-_12121831 | 21.32 |
ENSMUST00000021750.15
ENSMUST00000170156.3 ENSMUST00000220597.2 |
Ryr2
|
ryanodine receptor 2, cardiac |
chr15_+_78798116 | 20.94 |
ENSMUST00000089378.5
|
Pdxp
|
pyridoxal (pyridoxine, vitamin B6) phosphatase |
chr16_+_94171477 | 20.91 |
ENSMUST00000117648.9
ENSMUST00000147352.8 ENSMUST00000150346.8 ENSMUST00000155692.8 ENSMUST00000153988.9 ENSMUST00000139513.9 ENSMUST00000141856.8 ENSMUST00000152117.8 ENSMUST00000150097.8 ENSMUST00000122895.8 ENSMUST00000151770.8 ENSMUST00000231569.2 ENSMUST00000147046.8 ENSMUST00000149885.8 ENSMUST00000127667.8 ENSMUST00000119131.3 ENSMUST00000145883.2 |
Ttc3
|
tetratricopeptide repeat domain 3 |
chr15_-_79389442 | 20.90 |
ENSMUST00000057801.8
|
Kcnj4
|
potassium inwardly-rectifying channel, subfamily J, member 4 |
chr11_+_80367839 | 20.78 |
ENSMUST00000053413.12
ENSMUST00000147694.2 |
Cdk5r1
|
cyclin-dependent kinase 5, regulatory subunit 1 (p35) |
chr16_-_20440005 | 20.75 |
ENSMUST00000052939.4
|
Camk2n2
|
calcium/calmodulin-dependent protein kinase II inhibitor 2 |
chr2_+_28083105 | 20.63 |
ENSMUST00000100244.10
|
Olfm1
|
olfactomedin 1 |
chr14_-_29443792 | 20.51 |
ENSMUST00000022567.9
|
Cacna2d3
|
calcium channel, voltage-dependent, alpha2/delta subunit 3 |
chrX_-_72868544 | 20.44 |
ENSMUST00000002080.12
ENSMUST00000114438.3 |
Pdzd4
|
PDZ domain containing 4 |
chr7_+_44813363 | 20.30 |
ENSMUST00000085374.7
ENSMUST00000209634.2 |
Slc17a7
|
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7 |
chr5_-_108515740 | 20.08 |
ENSMUST00000197216.3
|
Gm42517
|
predicted gene 42517 |
chrX_-_72703652 | 20.02 |
ENSMUST00000114472.8
|
Pnck
|
pregnancy upregulated non-ubiquitously expressed CaM kinase |
chr15_+_100768776 | 19.97 |
ENSMUST00000108909.9
|
Scn8a
|
sodium channel, voltage-gated, type VIII, alpha |
chr15_-_75438457 | 19.96 |
ENSMUST00000163116.8
ENSMUST00000023241.12 |
Ly6h
|
lymphocyte antigen 6 complex, locus H |
chr2_+_31135813 | 19.91 |
ENSMUST00000000199.8
|
Ncs1
|
neuronal calcium sensor 1 |
chr7_-_30826376 | 19.89 |
ENSMUST00000098548.8
|
Scn1b
|
sodium channel, voltage-gated, type I, beta |
chr19_-_42420216 | 19.67 |
ENSMUST00000048630.8
ENSMUST00000238290.2 |
Crtac1
|
cartilage acidic protein 1 |
chr13_-_69887964 | 19.57 |
ENSMUST00000065118.7
|
Ube2ql1
|
ubiquitin-conjugating enzyme E2Q family-like 1 |
chr9_+_26645024 | 19.54 |
ENSMUST00000160899.8
ENSMUST00000161431.3 ENSMUST00000159799.8 |
B3gat1
|
beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P) |
chr4_+_48585135 | 19.50 |
ENSMUST00000030032.13
|
Tmeff1
|
transmembrane protein with EGF-like and two follistatin-like domains 1 |
chr15_+_87428483 | 19.47 |
ENSMUST00000230414.2
|
Tafa5
|
TAFA chemokine like family member 5 |
chr6_+_117988399 | 19.42 |
ENSMUST00000164960.4
|
Rasgef1a
|
RasGEF domain family, member 1A |
chr6_+_115111872 | 19.22 |
ENSMUST00000009538.12
ENSMUST00000203450.2 |
Syn2
|
synapsin II |
chr7_+_4693603 | 19.10 |
ENSMUST00000120836.8
|
Brsk1
|
BR serine/threonine kinase 1 |
chr2_+_119572770 | 19.10 |
ENSMUST00000028758.8
|
Itpka
|
inositol 1,4,5-trisphosphate 3-kinase A |
chr15_+_74388044 | 19.09 |
ENSMUST00000042035.16
|
Adgrb1
|
adhesion G protein-coupled receptor B1 |
chr15_-_79688910 | 19.08 |
ENSMUST00000175858.10
ENSMUST00000023057.10 |
Nptxr
|
neuronal pentraxin receptor |
chrX_+_7504913 | 18.67 |
ENSMUST00000128890.2
|
Syp
|
synaptophysin |
chr7_-_46782448 | 18.62 |
ENSMUST00000033142.13
|
Ptpn5
|
protein tyrosine phosphatase, non-receptor type 5 |
chr9_+_110074574 | 18.58 |
ENSMUST00000197850.5
|
Cspg5
|
chondroitin sulfate proteoglycan 5 |
chr15_-_75438660 | 18.58 |
ENSMUST00000065417.15
|
Ly6h
|
lymphocyte antigen 6 complex, locus H |
chr11_+_77821626 | 18.44 |
ENSMUST00000093995.10
ENSMUST00000000646.14 |
Sez6
|
seizure related gene 6 |
chr10_-_79975181 | 18.34 |
ENSMUST00000105369.8
|
Cbarp
|
calcium channel, voltage-dependent, beta subunit associated regulatory protein |
chr15_-_75439013 | 18.31 |
ENSMUST00000156032.2
ENSMUST00000127095.8 |
Ly6h
|
lymphocyte antigen 6 complex, locus H |
chr2_+_28082943 | 18.27 |
ENSMUST00000113920.8
|
Olfm1
|
olfactomedin 1 |
chr2_-_179746227 | 18.14 |
ENSMUST00000056480.10
|
Hrh3
|
histamine receptor H3 |
chr9_-_86762467 | 18.09 |
ENSMUST00000074501.12
ENSMUST00000239074.2 ENSMUST00000098495.10 ENSMUST00000036347.13 ENSMUST00000074468.13 |
Snap91
|
synaptosomal-associated protein 91 |
chr15_-_83609127 | 18.00 |
ENSMUST00000171496.9
ENSMUST00000043634.12 ENSMUST00000076060.12 ENSMUST00000016907.8 |
Scube1
|
signal peptide, CUB domain, EGF-like 1 |
chr9_-_20657643 | 17.95 |
ENSMUST00000215999.2
|
Olfm2
|
olfactomedin 2 |
chr4_-_151946155 | 17.90 |
ENSMUST00000049790.14
|
Camta1
|
calmodulin binding transcription activator 1 |
chr5_+_37399284 | 17.90 |
ENSMUST00000202434.4
ENSMUST00000114158.9 |
Crmp1
|
collapsin response mediator protein 1 |
chr11_-_72026547 | 17.83 |
ENSMUST00000108508.3
ENSMUST00000075258.13 |
Pitpnm3
|
PITPNM family member 3 |
chr6_+_115111860 | 17.76 |
ENSMUST00000169345.4
|
Syn2
|
synapsin II |
chr15_+_100768551 | 17.71 |
ENSMUST00000082209.13
|
Scn8a
|
sodium channel, voltage-gated, type VIII, alpha |
chr7_+_64151435 | 17.58 |
ENSMUST00000032732.15
|
Apba2
|
amyloid beta (A4) precursor protein-binding, family A, member 2 |
chr7_+_141503411 | 17.50 |
ENSMUST00000078200.12
ENSMUST00000018971.15 |
Brsk2
|
BR serine/threonine kinase 2 |
chr2_-_73605684 | 17.42 |
ENSMUST00000112024.10
ENSMUST00000180045.8 |
Chn1
|
chimerin 1 |
chr11_+_98727611 | 17.39 |
ENSMUST00000107479.3
|
Rapgefl1
|
Rap guanine nucleotide exchange factor (GEF)-like 1 |
chr17_+_27904155 | 17.32 |
ENSMUST00000231669.2
ENSMUST00000097360.3 ENSMUST00000231236.2 |
Pacsin1
|
protein kinase C and casein kinase substrate in neurons 1 |
chr9_-_56703422 | 17.28 |
ENSMUST00000210032.2
|
Lingo1
|
leucine rich repeat and Ig domain containing 1 |
chr12_-_70394074 | 17.27 |
ENSMUST00000223160.2
ENSMUST00000222316.2 ENSMUST00000167755.3 ENSMUST00000110520.10 ENSMUST00000110522.10 ENSMUST00000221041.2 ENSMUST00000222603.3 |
Trim9
|
tripartite motif-containing 9 |
chr15_+_79975520 | 17.19 |
ENSMUST00000009728.13
ENSMUST00000009727.12 |
Syngr1
|
synaptogyrin 1 |
chr1_-_79836344 | 17.02 |
ENSMUST00000027467.11
|
Serpine2
|
serine (or cysteine) peptidase inhibitor, clade E, member 2 |
chr5_+_37025810 | 16.90 |
ENSMUST00000031003.11
|
Ppp2r2c
|
protein phosphatase 2, regulatory subunit B, gamma |
chr1_-_184731672 | 16.89 |
ENSMUST00000192657.2
ENSMUST00000027929.10 |
Mark1
|
MAP/microtubule affinity regulating kinase 1 |
chr10_-_116309764 | 16.88 |
ENSMUST00000068233.11
|
Kcnmb4
|
potassium large conductance calcium-activated channel, subfamily M, beta member 4 |
chr1_+_182591425 | 16.86 |
ENSMUST00000155229.7
ENSMUST00000153348.8 |
Susd4
|
sushi domain containing 4 |
chr19_-_46306506 | 16.85 |
ENSMUST00000224556.2
|
Psd
|
pleckstrin and Sec7 domain containing |
chr4_+_48585275 | 16.81 |
ENSMUST00000123476.8
|
Tmeff1
|
transmembrane protein with EGF-like and two follistatin-like domains 1 |
chr7_+_99876515 | 16.81 |
ENSMUST00000084935.11
|
Pgm2l1
|
phosphoglucomutase 2-like 1 |
chr9_-_20638233 | 16.69 |
ENSMUST00000217198.2
|
Olfm2
|
olfactomedin 2 |
chr15_-_79718462 | 16.69 |
ENSMUST00000148358.2
|
Cbx6
|
chromobox 6 |
chr6_-_113172340 | 16.67 |
ENSMUST00000162280.2
|
Lhfpl4
|
lipoma HMGIC fusion partner-like protein 4 |
chr5_+_144482693 | 16.57 |
ENSMUST00000071782.8
|
Nptx2
|
neuronal pentraxin 2 |
chr11_-_69728560 | 16.53 |
ENSMUST00000108634.9
|
Nlgn2
|
neuroligin 2 |
chr8_-_4309257 | 16.50 |
ENSMUST00000053252.9
|
Ctxn1
|
cortexin 1 |
chr10_-_127098932 | 16.45 |
ENSMUST00000217895.2
|
Kif5a
|
kinesin family member 5A |
chr19_+_47167259 | 16.44 |
ENSMUST00000111808.11
|
Neurl1a
|
neuralized E3 ubiquitin protein ligase 1A |
chr7_+_141503719 | 16.44 |
ENSMUST00000105989.9
ENSMUST00000075528.12 ENSMUST00000174499.8 |
Brsk2
|
BR serine/threonine kinase 2 |
chr7_-_30144933 | 16.42 |
ENSMUST00000006828.9
|
Aplp1
|
amyloid beta (A4) precursor-like protein 1 |
chr7_+_40547608 | 16.42 |
ENSMUST00000044705.12
|
Vstm2b
|
V-set and transmembrane domain containing 2B |
chr5_-_115332343 | 16.41 |
ENSMUST00000112113.8
|
Cabp1
|
calcium binding protein 1 |
chr9_+_107812873 | 16.30 |
ENSMUST00000035700.14
|
Camkv
|
CaM kinase-like vesicle-associated |
chr5_-_108697857 | 16.30 |
ENSMUST00000129040.2
ENSMUST00000046892.10 |
Cplx1
|
complexin 1 |
chr1_+_66507523 | 16.14 |
ENSMUST00000061620.17
ENSMUST00000212557.3 |
Unc80
|
unc-80, NALCN activator |
chr7_+_46045862 | 16.14 |
ENSMUST00000025202.8
|
Kcnc1
|
potassium voltage gated channel, Shaw-related subfamily, member 1 |
chr2_+_156455583 | 16.03 |
ENSMUST00000109567.10
ENSMUST00000169464.9 |
Dlgap4
|
DLG associated protein 4 |
chr11_-_94364914 | 16.02 |
ENSMUST00000107786.8
ENSMUST00000107791.8 ENSMUST00000103166.9 ENSMUST00000107792.8 ENSMUST00000100561.10 ENSMUST00000107793.8 ENSMUST00000107788.8 ENSMUST00000107790.8 ENSMUST00000107789.8 ENSMUST00000107785.2 ENSMUST00000021234.15 |
Cacna1g
|
calcium channel, voltage-dependent, T type, alpha 1G subunit |
chr9_+_65008735 | 15.93 |
ENSMUST00000213533.2
ENSMUST00000035499.5 ENSMUST00000077696.13 ENSMUST00000166273.2 |
Igdcc4
|
immunoglobulin superfamily, DCC subclass, member 4 |
chr10_+_40759815 | 15.91 |
ENSMUST00000105509.2
|
Wasf1
|
WASP family, member 1 |
chr10_+_126914755 | 15.86 |
ENSMUST00000039259.7
ENSMUST00000217941.2 |
Agap2
|
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 |
chr2_+_25767795 | 15.74 |
ENSMUST00000114172.6
ENSMUST00000114176.9 ENSMUST00000037580.13 ENSMUST00000197917.5 |
Kcnt1
|
potassium channel, subfamily T, member 1 |
chr11_-_77380492 | 15.72 |
ENSMUST00000037593.14
ENSMUST00000092892.10 |
Ankrd13b
|
ankyrin repeat domain 13b |
chr12_-_109034099 | 15.64 |
ENSMUST00000190647.3
|
Begain
|
brain-enriched guanylate kinase-associated |
chr5_-_139115417 | 15.63 |
ENSMUST00000026973.14
|
Prkar1b
|
protein kinase, cAMP dependent regulatory, type I beta |
chr15_+_89383799 | 15.59 |
ENSMUST00000109309.9
|
Shank3
|
SH3 and multiple ankyrin repeat domains 3 |
chr12_+_44375747 | 15.56 |
ENSMUST00000020939.16
ENSMUST00000220126.2 |
Nrcam
|
neuronal cell adhesion molecule |
chr19_+_10366753 | 15.33 |
ENSMUST00000169121.9
ENSMUST00000076968.11 ENSMUST00000235479.2 ENSMUST00000223586.2 ENSMUST00000235784.2 ENSMUST00000224135.3 ENSMUST00000225452.3 ENSMUST00000237366.2 |
Syt7
|
synaptotagmin VII |
chr2_+_145009625 | 15.30 |
ENSMUST00000110007.8
|
Slc24a3
|
solute carrier family 24 (sodium/potassium/calcium exchanger), member 3 |
chr15_+_89384317 | 15.28 |
ENSMUST00000135214.2
|
Shank3
|
SH3 and multiple ankyrin repeat domains 3 |
chr6_+_114108190 | 15.15 |
ENSMUST00000032451.9
|
Slc6a11
|
solute carrier family 6 (neurotransmitter transporter, GABA), member 11 |
chr15_-_25413838 | 15.13 |
ENSMUST00000058845.9
|
Basp1
|
brain abundant, membrane attached signal protein 1 |
chr3_-_80820835 | 15.12 |
ENSMUST00000107743.8
ENSMUST00000029654.15 |
Glrb
|
glycine receptor, beta subunit |
chr7_-_142211203 | 15.05 |
ENSMUST00000097936.9
ENSMUST00000000033.12 |
Igf2
|
insulin-like growth factor 2 |
chr15_+_99122742 | 15.04 |
ENSMUST00000041415.5
|
Kcnh3
|
potassium voltage-gated channel, subfamily H (eag-related), member 3 |
chr11_+_116809669 | 15.04 |
ENSMUST00000103027.10
|
Mgat5b
|
mannoside acetylglucosaminyltransferase 5, isoenzyme B |
chr2_-_73605387 | 14.96 |
ENSMUST00000166199.9
|
Chn1
|
chimerin 1 |
chr3_-_152373997 | 14.92 |
ENSMUST00000045262.11
|
Ak5
|
adenylate kinase 5 |
chr4_-_11966367 | 14.85 |
ENSMUST00000056050.5
ENSMUST00000108299.2 ENSMUST00000108297.3 |
Pdp1
|
pyruvate dehyrogenase phosphatase catalytic subunit 1 |
chr12_+_80565764 | 14.82 |
ENSMUST00000021558.8
|
Galnt16
|
polypeptide N-acetylgalactosaminyltransferase 16 |
chr15_+_87509413 | 14.76 |
ENSMUST00000068088.8
|
Tafa5
|
TAFA chemokine like family member 5 |
chr16_+_17945471 | 14.73 |
ENSMUST00000059589.6
|
Rtn4r
|
reticulon 4 receptor |
chr15_-_79718423 | 14.72 |
ENSMUST00000109623.8
ENSMUST00000109625.8 ENSMUST00000023060.13 ENSMUST00000089299.6 |
Cbx6
Npcd
|
chromobox 6 neuronal pentraxin chromo domain |
chr16_-_18445172 | 14.69 |
ENSMUST00000231335.2
ENSMUST00000232653.2 |
Gm49601
Septin5
|
predicted gene, 49601 septin 5 |
chr7_-_30234422 | 14.66 |
ENSMUST00000208522.2
ENSMUST00000207860.2 ENSMUST00000208538.2 |
Arhgap33
|
Rho GTPase activating protein 33 |
chr6_-_42301574 | 14.66 |
ENSMUST00000031891.15
ENSMUST00000143278.8 |
Fam131b
|
family with sequence similarity 131, member B |
chr11_-_107685383 | 14.61 |
ENSMUST00000021066.4
|
Cacng4
|
calcium channel, voltage-dependent, gamma subunit 4 |
chr13_-_54897425 | 14.60 |
ENSMUST00000099506.2
|
Gprin1
|
G protein-regulated inducer of neurite outgrowth 1 |
chr7_+_27353331 | 14.60 |
ENSMUST00000008088.9
|
Ttc9b
|
tetratricopeptide repeat domain 9B |
chr11_+_98632696 | 14.55 |
ENSMUST00000103139.11
|
Thra
|
thyroid hormone receptor alpha |
chr7_+_121888520 | 14.53 |
ENSMUST00000064989.12
ENSMUST00000064921.5 |
Prkcb
|
protein kinase C, beta |
chr19_+_6468761 | 14.48 |
ENSMUST00000113462.8
ENSMUST00000077182.13 ENSMUST00000236635.2 ENSMUST00000113461.8 |
Nrxn2
|
neurexin II |
chr2_-_180777025 | 14.47 |
ENSMUST00000103051.9
ENSMUST00000016491.14 |
Kcnq2
|
potassium voltage-gated channel, subfamily Q, member 2 |
chr11_-_95405368 | 14.39 |
ENSMUST00000058866.8
|
Nxph3
|
neurexophilin 3 |
chr8_+_120173458 | 14.33 |
ENSMUST00000098363.10
|
Necab2
|
N-terminal EF-hand calcium binding protein 2 |
chr5_-_5430172 | 14.31 |
ENSMUST00000030763.13
|
Cdk14
|
cyclin-dependent kinase 14 |
chr4_+_152423075 | 14.27 |
ENSMUST00000030775.12
ENSMUST00000164662.8 |
Chd5
|
chromodomain helicase DNA binding protein 5 |
chr4_-_46991842 | 14.23 |
ENSMUST00000107749.4
|
Gabbr2
|
gamma-aminobutyric acid (GABA) B receptor, 2 |
chr3_-_138780894 | 14.21 |
ENSMUST00000196280.5
ENSMUST00000200396.2 |
Rap1gds1
|
RAP1, GTP-GDP dissociation stimulator 1 |
chr1_-_37758863 | 14.16 |
ENSMUST00000160589.2
|
Cracdl
|
capping protein inhibiting regulator of actin like |
chr17_-_26420300 | 14.04 |
ENSMUST00000025019.9
|
Arhgdig
|
Rho GDP dissociation inhibitor (GDI) gamma |
chr3_+_68401536 | 13.97 |
ENSMUST00000182719.8
|
Schip1
|
schwannomin interacting protein 1 |
chr7_+_29991101 | 13.94 |
ENSMUST00000150892.2
ENSMUST00000126216.2 ENSMUST00000014065.16 |
Clip3
|
CAP-GLY domain containing linker protein 3 |
chr7_+_3381434 | 13.93 |
ENSMUST00000092891.6
|
Cacng7
|
calcium channel, voltage-dependent, gamma subunit 7 |
chr7_-_138768374 | 13.87 |
ENSMUST00000016125.12
|
Stk32c
|
serine/threonine kinase 32C |
chr7_+_28151370 | 13.85 |
ENSMUST00000190954.7
|
Lrfn1
|
leucine rich repeat and fibronectin type III domain containing 1 |
chr4_+_85123654 | 13.85 |
ENSMUST00000030212.15
ENSMUST00000107189.8 ENSMUST00000107184.8 |
Sh3gl2
|
SH3-domain GRB2-like 2 |
chr7_+_24181416 | 13.80 |
ENSMUST00000068023.8
|
Cadm4
|
cell adhesion molecule 4 |
chr4_+_152423344 | 13.69 |
ENSMUST00000005175.5
|
Chd5
|
chromodomain helicase DNA binding protein 5 |
chr2_+_156317416 | 13.67 |
ENSMUST00000029155.16
|
Epb41l1
|
erythrocyte membrane protein band 4.1 like 1 |
chr8_-_100143029 | 13.66 |
ENSMUST00000155527.8
ENSMUST00000142129.8 ENSMUST00000093249.11 ENSMUST00000142475.3 ENSMUST00000128860.8 |
Cdh8
|
cadherin 8 |
chr15_-_95426419 | 13.64 |
ENSMUST00000229933.2
ENSMUST00000166170.9 |
Nell2
|
NEL-like 2 |
chr14_-_20596580 | 13.61 |
ENSMUST00000022355.11
ENSMUST00000161445.8 ENSMUST00000159027.8 |
Ppp3cb
|
protein phosphatase 3, catalytic subunit, beta isoform |
chr15_+_89407954 | 13.58 |
ENSMUST00000230807.2
|
Shank3
|
SH3 and multiple ankyrin repeat domains 3 |
chr4_-_129015493 | 13.58 |
ENSMUST00000135763.2
ENSMUST00000149763.3 ENSMUST00000164649.8 |
Hpca
|
hippocalcin |
chr9_+_58489523 | 13.57 |
ENSMUST00000177292.8
ENSMUST00000085651.12 ENSMUST00000176557.8 ENSMUST00000114121.11 ENSMUST00000177064.8 |
Nptn
|
neuroplastin |
chr11_-_69451012 | 13.54 |
ENSMUST00000004036.6
|
Efnb3
|
ephrin B3 |
chr10_-_70435114 | 13.49 |
ENSMUST00000046513.10
|
Phyhipl
|
phytanoyl-CoA hydroxylase interacting protein-like |
chr7_-_127423641 | 13.44 |
ENSMUST00000106267.5
|
Stx1b
|
syntaxin 1B |
chr9_-_56542908 | 13.40 |
ENSMUST00000114256.2
|
Lingo1
|
leucine rich repeat and Ig domain containing 1 |
chr19_-_5148506 | 13.22 |
ENSMUST00000025805.8
|
Cnih2
|
cornichon family AMPA receptor auxiliary protein 2 |
chr7_-_30750856 | 13.20 |
ENSMUST00000073892.6
|
Fxyd7
|
FXYD domain-containing ion transport regulator 7 |
chr6_-_88851579 | 13.19 |
ENSMUST00000061262.11
ENSMUST00000140455.8 ENSMUST00000145780.2 |
Podxl2
|
podocalyxin-like 2 |
chr9_+_74978429 | 13.18 |
ENSMUST00000123128.8
|
Myo5a
|
myosin VA |
chr4_-_153567221 | 13.13 |
ENSMUST00000105646.3
|
Ajap1
|
adherens junction associated protein 1 |
chr15_-_37792237 | 13.12 |
ENSMUST00000168992.8
ENSMUST00000148652.9 |
Ncald
|
neurocalcin delta |
chr11_-_102187445 | 13.06 |
ENSMUST00000107132.3
ENSMUST00000073234.9 |
Atxn7l3
|
ataxin 7-like 3 |
chr8_-_124586159 | 13.05 |
ENSMUST00000034452.12
|
Ccsap
|
centriole, cilia and spindle associated protein |
chr2_+_158452651 | 13.05 |
ENSMUST00000045738.5
|
Slc32a1
|
solute carrier family 32 (GABA vesicular transporter), member 1 |
chr7_-_4847673 | 13.03 |
ENSMUST00000066041.12
ENSMUST00000119433.4 |
Shisa7
|
shisa family member 7 |
chr2_+_92430043 | 12.99 |
ENSMUST00000065797.7
|
Chst1
|
carbohydrate sulfotransferase 1 |
chr9_-_37464200 | 12.94 |
ENSMUST00000065668.12
|
Nrgn
|
neurogranin |
chr10_-_67748461 | 12.91 |
ENSMUST00000064656.8
|
Zfp365
|
zinc finger protein 365 |
chr10_+_74802996 | 12.91 |
ENSMUST00000037813.5
|
Gnaz
|
guanine nucleotide binding protein, alpha z subunit |
chr11_-_116303791 | 12.90 |
ENSMUST00000100202.10
ENSMUST00000106398.9 |
Rnf157
|
ring finger protein 157 |
chr11_+_77353218 | 12.85 |
ENSMUST00000102493.8
|
Coro6
|
coronin 6 |
chr4_+_149671012 | 12.77 |
ENSMUST00000039144.7
|
Clstn1
|
calsyntenin 1 |
chr9_-_70048766 | 12.75 |
ENSMUST00000034749.16
|
Fam81a
|
family with sequence similarity 81, member A |
chr7_+_26958150 | 12.74 |
ENSMUST00000079258.7
|
Numbl
|
numb-like |
chr7_+_19016536 | 12.71 |
ENSMUST00000032559.17
|
Rtn2
|
reticulon 2 (Z-band associated protein) |
chr4_+_155976279 | 12.69 |
ENSMUST00000105584.10
ENSMUST00000079031.6 |
Acap3
|
ArfGAP with coiled-coil, ankyrin repeat and PH domains 3 |
chr6_-_42301488 | 12.66 |
ENSMUST00000095974.4
|
Fam131b
|
family with sequence similarity 131, member B |
chr6_+_22875494 | 12.65 |
ENSMUST00000090568.7
|
Ptprz1
|
protein tyrosine phosphatase, receptor type Z, polypeptide 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
19.4 | 58.3 | GO:0060466 | activation of meiosis involved in egg activation(GO:0060466) |
14.7 | 44.0 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
12.2 | 61.1 | GO:0098971 | anterograde dendritic transport of neurotransmitter receptor complex(GO:0098971) |
10.8 | 65.0 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
10.1 | 30.4 | GO:0040040 | thermosensory behavior(GO:0040040) |
10.0 | 40.0 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
10.0 | 29.9 | GO:0061107 | seminal vesicle development(GO:0061107) |
9.3 | 55.7 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
9.1 | 27.2 | GO:0030824 | negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
8.8 | 44.2 | GO:1904048 | regulation of spontaneous neurotransmitter secretion(GO:1904048) |
8.7 | 26.1 | GO:1990926 | short-term synaptic potentiation(GO:1990926) |
8.6 | 103.3 | GO:0023041 | neuronal signal transduction(GO:0023041) |
8.4 | 33.8 | GO:0021586 | pons maturation(GO:0021586) |
8.2 | 24.6 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
8.1 | 24.3 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
7.7 | 23.0 | GO:0042822 | pyridoxal phosphate metabolic process(GO:0042822) |
6.9 | 20.6 | GO:0097401 | synaptic vesicle lumen acidification(GO:0097401) |
6.9 | 27.4 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
6.7 | 20.0 | GO:0071874 | cellular response to norepinephrine stimulus(GO:0071874) |
6.6 | 19.8 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
6.5 | 19.4 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
6.5 | 58.2 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
6.4 | 25.5 | GO:1904616 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
6.3 | 12.6 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
6.3 | 18.9 | GO:0003220 | left ventricular cardiac muscle tissue morphogenesis(GO:0003220) |
6.3 | 18.9 | GO:1904020 | regulation of G-protein coupled receptor internalization(GO:1904020) |
6.2 | 24.8 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
6.2 | 67.7 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
6.0 | 18.0 | GO:0099552 | trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
5.8 | 17.4 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
5.8 | 28.8 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
5.7 | 34.4 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
5.7 | 39.6 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
5.6 | 33.9 | GO:0050760 | thymidylate synthase biosynthetic process(GO:0050757) regulation of thymidylate synthase biosynthetic process(GO:0050758) negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
5.6 | 16.9 | GO:0003360 | brainstem development(GO:0003360) |
5.6 | 16.8 | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
5.5 | 16.6 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
5.5 | 27.6 | GO:1902163 | negative regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902163) |
5.5 | 16.5 | GO:0001966 | thigmotaxis(GO:0001966) |
5.1 | 20.5 | GO:1904209 | regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
5.1 | 25.3 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
5.0 | 45.3 | GO:0098909 | regulation of cardiac muscle cell action potential involved in regulation of contraction(GO:0098909) |
4.9 | 103.6 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
4.9 | 19.6 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
4.9 | 19.5 | GO:0051582 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
4.7 | 14.2 | GO:0021577 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
4.7 | 4.7 | GO:0099542 | trans-synaptic signaling by lipid(GO:0099541) trans-synaptic signaling by endocannabinoid(GO:0099542) |
4.6 | 45.8 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
4.6 | 22.8 | GO:0034164 | negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
4.5 | 13.5 | GO:0098928 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
4.4 | 17.8 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
4.4 | 21.9 | GO:0044849 | estrous cycle(GO:0044849) |
4.4 | 13.1 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
4.4 | 30.5 | GO:0009405 | pathogenesis(GO:0009405) |
4.3 | 17.4 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
4.3 | 17.3 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
4.3 | 21.6 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
4.3 | 8.6 | GO:0008038 | neuron recognition(GO:0008038) |
4.3 | 34.2 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
4.2 | 37.9 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
4.2 | 21.0 | GO:1990034 | calcium ion export from cell(GO:1990034) |
4.2 | 12.5 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
4.0 | 24.3 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
4.0 | 32.4 | GO:0098712 | L-glutamate import across plasma membrane(GO:0098712) |
4.0 | 32.0 | GO:0098828 | modulation of inhibitory postsynaptic potential(GO:0098828) |
4.0 | 12.0 | GO:0072720 | response to dithiothreitol(GO:0072720) |
4.0 | 15.9 | GO:1904799 | regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) |
3.9 | 15.6 | GO:0031133 | regulation of axon diameter(GO:0031133) |
3.9 | 15.5 | GO:0035524 | proline transmembrane transport(GO:0035524) |
3.8 | 26.8 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
3.8 | 7.6 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
3.8 | 11.4 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
3.8 | 3.8 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
3.8 | 15.1 | GO:1900149 | positive regulation of Schwann cell migration(GO:1900149) |
3.8 | 11.3 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
3.8 | 3.8 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
3.8 | 41.3 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
3.7 | 52.0 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
3.7 | 3.7 | GO:2000769 | regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000769) positive regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000771) |
3.7 | 3.7 | GO:1902996 | neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) |
3.6 | 18.0 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
3.6 | 14.3 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
3.5 | 10.6 | GO:0021852 | pyramidal neuron migration(GO:0021852) |
3.5 | 21.3 | GO:0099551 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
3.5 | 14.1 | GO:0048691 | positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) |
3.5 | 14.1 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
3.5 | 10.4 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
3.5 | 34.6 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
3.4 | 10.3 | GO:1902277 | negative regulation of pancreatic amylase secretion(GO:1902277) |
3.4 | 71.9 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
3.4 | 16.8 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
3.3 | 63.6 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
3.3 | 6.6 | GO:0001661 | conditioned taste aversion(GO:0001661) |
3.3 | 16.5 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
3.3 | 3.3 | GO:1904170 | regulation of bleb assembly(GO:1904170) positive regulation of bleb assembly(GO:1904172) |
3.3 | 13.1 | GO:0061534 | gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
3.2 | 13.0 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
3.2 | 12.9 | GO:0030450 | regulation of complement activation, classical pathway(GO:0030450) |
3.2 | 3.2 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
3.2 | 15.9 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
3.1 | 37.7 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
3.1 | 72.2 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
3.1 | 9.3 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
3.1 | 15.4 | GO:0035617 | stress granule disassembly(GO:0035617) |
3.1 | 12.3 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
3.1 | 15.4 | GO:0032901 | positive regulation of neurotrophin production(GO:0032901) |
3.0 | 21.0 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
3.0 | 21.0 | GO:0071543 | diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
3.0 | 6.0 | GO:0099612 | protein localization to axon(GO:0099612) |
3.0 | 9.0 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
3.0 | 6.0 | GO:0036394 | amylase secretion(GO:0036394) |
3.0 | 23.9 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
3.0 | 91.8 | GO:0098926 | postsynaptic signal transduction(GO:0098926) |
2.9 | 17.7 | GO:0099527 | postsynapse to nucleus signaling pathway(GO:0099527) |
2.9 | 14.6 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
2.9 | 11.6 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
2.9 | 2.9 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
2.9 | 20.3 | GO:0007258 | JUN phosphorylation(GO:0007258) |
2.9 | 8.7 | GO:0099547 | regulation of translation at synapse, modulating synaptic transmission(GO:0099547) regulation of translation at postsynapse, modulating synaptic transmission(GO:0099578) positive regulation of intracellular transport of viral material(GO:1901254) |
2.9 | 11.5 | GO:1904708 | granulosa cell apoptotic process(GO:1904700) regulation of granulosa cell apoptotic process(GO:1904708) |
2.9 | 17.2 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
2.8 | 96.4 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
2.8 | 298.8 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
2.8 | 19.7 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
2.8 | 11.3 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
2.8 | 5.6 | GO:0051892 | negative regulation of cardioblast differentiation(GO:0051892) |
2.8 | 115.2 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
2.8 | 36.2 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
2.8 | 5.6 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
2.8 | 19.4 | GO:0098881 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
2.8 | 38.7 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
2.8 | 8.3 | GO:0010615 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
2.8 | 13.8 | GO:0098886 | modification of dendritic spine(GO:0098886) |
2.7 | 16.3 | GO:0006543 | glutamine catabolic process(GO:0006543) |
2.6 | 31.5 | GO:2000576 | positive regulation of microtubule motor activity(GO:2000576) |
2.6 | 34.2 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
2.6 | 7.8 | GO:0006500 | N-terminal protein palmitoylation(GO:0006500) |
2.6 | 2.6 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
2.6 | 7.8 | GO:1904456 | negative regulation of neuronal action potential(GO:1904456) |
2.6 | 13.0 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
2.6 | 25.9 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
2.6 | 2.6 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
2.6 | 7.7 | GO:0098749 | cerebellar neuron development(GO:0098749) |
2.6 | 2.6 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
2.6 | 18.0 | GO:0051012 | microtubule sliding(GO:0051012) |
2.6 | 5.1 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
2.6 | 15.3 | GO:0016198 | axon choice point recognition(GO:0016198) |
2.5 | 20.4 | GO:0033058 | directional locomotion(GO:0033058) |
2.5 | 5.1 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
2.5 | 2.5 | GO:2001107 | negative regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001107) |
2.5 | 12.7 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
2.4 | 36.2 | GO:0007413 | axonal fasciculation(GO:0007413) |
2.4 | 30.8 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
2.4 | 18.9 | GO:0005513 | detection of calcium ion(GO:0005513) |
2.3 | 9.4 | GO:0090222 | centrosome-templated microtubule nucleation(GO:0090222) |
2.3 | 14.0 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
2.3 | 7.0 | GO:0072034 | renal vesicle induction(GO:0072034) |
2.3 | 13.9 | GO:1901660 | calcium ion export(GO:1901660) |
2.3 | 9.2 | GO:0098582 | innate vocalization behavior(GO:0098582) |
2.3 | 11.5 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
2.3 | 9.2 | GO:0036114 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
2.3 | 4.6 | GO:0031179 | peptide modification(GO:0031179) |
2.3 | 4.6 | GO:0021637 | trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
2.3 | 13.6 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
2.3 | 9.0 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
2.2 | 15.7 | GO:0015824 | proline transport(GO:0015824) |
2.2 | 4.5 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
2.2 | 24.6 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
2.2 | 13.4 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
2.2 | 6.7 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
2.2 | 8.9 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
2.2 | 11.1 | GO:0010747 | positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) |
2.2 | 4.4 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
2.2 | 6.6 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
2.2 | 4.4 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
2.2 | 6.6 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
2.2 | 2.2 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
2.2 | 8.7 | GO:0050973 | detection of mechanical stimulus involved in equilibrioception(GO:0050973) |
2.2 | 69.0 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
2.1 | 2.1 | GO:0032241 | positive regulation of nucleobase-containing compound transport(GO:0032241) |
2.1 | 27.8 | GO:0070842 | aggresome assembly(GO:0070842) |
2.1 | 6.4 | GO:0045212 | neurotransmitter receptor biosynthetic process(GO:0045212) |
2.1 | 6.4 | GO:0002380 | immunoglobulin secretion involved in immune response(GO:0002380) |
2.1 | 34.1 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
2.1 | 12.7 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
2.1 | 16.8 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
2.1 | 33.3 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
2.1 | 37.4 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
2.1 | 8.2 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
2.0 | 4.1 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
2.0 | 4.1 | GO:0045760 | positive regulation of action potential(GO:0045760) positive regulation of neuronal action potential(GO:1904457) |
2.0 | 2.0 | GO:0097688 | glutamate receptor clustering(GO:0097688) |
2.0 | 6.1 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
2.0 | 8.0 | GO:0035934 | corticosterone secretion(GO:0035934) |
2.0 | 2.0 | GO:0045763 | negative regulation of cellular amino acid metabolic process(GO:0045763) |
2.0 | 6.0 | GO:0098885 | modification of postsynaptic actin cytoskeleton(GO:0098885) |
2.0 | 25.8 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
2.0 | 35.4 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
2.0 | 5.9 | GO:1900477 | negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter(GO:1900477) |
2.0 | 5.9 | GO:0046168 | glycerol-3-phosphate catabolic process(GO:0046168) |
2.0 | 15.7 | GO:0060313 | negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
2.0 | 3.9 | GO:0042940 | D-amino acid transport(GO:0042940) |
2.0 | 11.7 | GO:0032226 | positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
1.9 | 1.9 | GO:2000405 | negative regulation of T cell migration(GO:2000405) |
1.9 | 3.9 | GO:0032230 | positive regulation of synaptic transmission, GABAergic(GO:0032230) |
1.9 | 5.8 | GO:0097535 | lymphoid lineage cell migration(GO:0097534) lymphoid lineage cell migration into thymus(GO:0097535) |
1.9 | 1.9 | GO:1903944 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
1.9 | 5.8 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
1.9 | 9.7 | GO:0001830 | trophectodermal cell fate commitment(GO:0001830) |
1.9 | 28.9 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
1.9 | 11.5 | GO:0014004 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
1.9 | 17.2 | GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) |
1.9 | 32.3 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
1.9 | 3.8 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
1.9 | 5.6 | GO:0030070 | insulin processing(GO:0030070) |
1.9 | 11.2 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
1.9 | 24.2 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
1.9 | 7.4 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
1.9 | 65.1 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
1.9 | 3.7 | GO:0002003 | angiotensin maturation(GO:0002003) |
1.9 | 5.6 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
1.8 | 5.5 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
1.8 | 20.1 | GO:0061001 | regulation of dendritic spine morphogenesis(GO:0061001) |
1.8 | 7.3 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
1.8 | 5.5 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
1.8 | 5.4 | GO:0034670 | chemotaxis to arachidonic acid(GO:0034670) response to arachidonic acid(GO:1904550) |
1.8 | 12.6 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
1.8 | 80.7 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
1.8 | 7.2 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
1.8 | 12.5 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
1.8 | 175.0 | GO:0099643 | neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
1.8 | 3.6 | GO:0015882 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
1.8 | 12.5 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
1.8 | 7.1 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
1.8 | 12.4 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
1.8 | 10.6 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
1.8 | 45.5 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
1.7 | 7.0 | GO:1904566 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
1.7 | 40.1 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
1.7 | 3.5 | GO:0006589 | octopamine biosynthetic process(GO:0006589) octopamine metabolic process(GO:0046333) |
1.7 | 1.7 | GO:0031104 | dendrite regeneration(GO:0031104) |
1.7 | 5.1 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
1.7 | 27.1 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
1.7 | 6.8 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
1.7 | 28.6 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
1.7 | 1.7 | GO:1905006 | negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905006) |
1.7 | 24.8 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
1.6 | 6.6 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
1.6 | 4.9 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) negative regulation of serotonin uptake(GO:0051612) |
1.6 | 17.8 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
1.6 | 100.4 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
1.6 | 9.6 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
1.6 | 6.4 | GO:0030421 | defecation(GO:0030421) |
1.6 | 3.2 | GO:2000744 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
1.6 | 3.2 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
1.6 | 4.8 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
1.6 | 4.8 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
1.6 | 4.7 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
1.6 | 4.7 | GO:0019417 | sulfur oxidation(GO:0019417) |
1.6 | 29.7 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
1.6 | 7.8 | GO:0015888 | thiamine transport(GO:0015888) |
1.6 | 15.6 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
1.6 | 17.1 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
1.6 | 17.1 | GO:0008063 | Toll signaling pathway(GO:0008063) |
1.6 | 3.1 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
1.6 | 4.7 | GO:2001160 | regulation of histone H3-K79 methylation(GO:2001160) |
1.5 | 7.7 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
1.5 | 7.7 | GO:0042069 | regulation of catecholamine metabolic process(GO:0042069) |
1.5 | 17.0 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
1.5 | 1.5 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
1.5 | 21.4 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
1.5 | 30.3 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
1.5 | 3.0 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
1.5 | 22.5 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
1.5 | 3.0 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
1.5 | 7.4 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
1.5 | 3.0 | GO:0035483 | gastric emptying(GO:0035483) |
1.5 | 5.9 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
1.5 | 19.2 | GO:1902993 | positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
1.5 | 5.9 | GO:2001225 | regulation of chloride transport(GO:2001225) |
1.5 | 1.5 | GO:1903525 | regulation of membrane tubulation(GO:1903525) positive regulation of membrane tubulation(GO:1903527) |
1.5 | 30.9 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
1.5 | 13.2 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
1.5 | 2.9 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
1.5 | 5.8 | GO:1905051 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
1.5 | 10.2 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
1.5 | 5.8 | GO:0016584 | nucleosome positioning(GO:0016584) |
1.5 | 17.4 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
1.5 | 8.7 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
1.5 | 7.3 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
1.4 | 5.8 | GO:2000657 | regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
1.4 | 1.4 | GO:0046959 | habituation(GO:0046959) |
1.4 | 8.6 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
1.4 | 52.7 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
1.4 | 12.8 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
1.4 | 1.4 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
1.4 | 2.8 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
1.4 | 8.4 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
1.4 | 8.4 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
1.4 | 1.4 | GO:0035332 | positive regulation of hippo signaling(GO:0035332) |
1.4 | 41.7 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
1.4 | 15.2 | GO:0035493 | SNARE complex assembly(GO:0035493) |
1.4 | 1.4 | GO:0021764 | amygdala development(GO:0021764) |
1.4 | 4.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
1.4 | 8.2 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
1.4 | 1.4 | GO:0072144 | glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
1.4 | 2.7 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
1.4 | 8.1 | GO:0035063 | nuclear speck organization(GO:0035063) |
1.3 | 1.3 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) |
1.3 | 37.7 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
1.3 | 6.7 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
1.3 | 2.7 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
1.3 | 2.7 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
1.3 | 1.3 | GO:1903281 | positive regulation of calcium:sodium antiporter activity(GO:1903281) |
1.3 | 4.0 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
1.3 | 5.3 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
1.3 | 5.3 | GO:0006226 | dUMP biosynthetic process(GO:0006226) |
1.3 | 4.0 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
1.3 | 2.6 | GO:0086098 | angiotensin-activated signaling pathway involved in heart process(GO:0086098) |
1.3 | 6.5 | GO:0001964 | startle response(GO:0001964) |
1.3 | 5.2 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
1.3 | 14.3 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
1.3 | 16.9 | GO:0022010 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
1.3 | 9.0 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
1.3 | 5.2 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
1.3 | 7.7 | GO:0035106 | operant conditioning(GO:0035106) |
1.3 | 10.2 | GO:0030800 | negative regulation of cyclic nucleotide metabolic process(GO:0030800) |
1.3 | 8.9 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
1.3 | 3.8 | GO:0035470 | positive regulation of vascular wound healing(GO:0035470) |
1.2 | 3.7 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
1.2 | 3.7 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
1.2 | 10.0 | GO:0060437 | lung growth(GO:0060437) |
1.2 | 5.0 | GO:0071313 | cellular response to caffeine(GO:0071313) |
1.2 | 5.0 | GO:0019858 | cytosine metabolic process(GO:0019858) |
1.2 | 12.4 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
1.2 | 8.6 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
1.2 | 4.9 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
1.2 | 6.1 | GO:0051932 | synaptic transmission, GABAergic(GO:0051932) |
1.2 | 19.4 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
1.2 | 9.7 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
1.2 | 3.6 | GO:0006592 | ornithine biosynthetic process(GO:0006592) |
1.2 | 3.6 | GO:0000349 | generation of catalytic spliceosome for first transesterification step(GO:0000349) |
1.2 | 22.7 | GO:0035640 | exploration behavior(GO:0035640) |
1.2 | 11.9 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
1.2 | 19.0 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
1.2 | 4.7 | GO:0030816 | positive regulation of cAMP metabolic process(GO:0030816) |
1.2 | 45.9 | GO:0050806 | positive regulation of synaptic transmission(GO:0050806) |
1.2 | 5.9 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
1.2 | 21.1 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
1.2 | 2.3 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
1.2 | 7.0 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
1.2 | 1.2 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
1.2 | 3.5 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
1.2 | 13.9 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) |
1.2 | 5.8 | GO:2000987 | positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
1.2 | 4.6 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
1.1 | 37.9 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
1.1 | 10.3 | GO:0031053 | primary miRNA processing(GO:0031053) |
1.1 | 35.5 | GO:0010107 | potassium ion import(GO:0010107) |
1.1 | 6.9 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
1.1 | 1.1 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
1.1 | 2.3 | GO:0046078 | dUMP metabolic process(GO:0046078) |
1.1 | 4.6 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
1.1 | 10.3 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
1.1 | 8.0 | GO:0007256 | activation of JNKK activity(GO:0007256) |
1.1 | 4.5 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
1.1 | 35.9 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
1.1 | 5.6 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
1.1 | 17.8 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
1.1 | 3.3 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
1.1 | 4.4 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
1.1 | 3.3 | GO:0060618 | nipple development(GO:0060618) |
1.1 | 8.8 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
1.1 | 8.8 | GO:0015844 | monoamine transport(GO:0015844) |
1.1 | 6.6 | GO:0097647 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
1.1 | 4.4 | GO:0001579 | medium-chain fatty acid transport(GO:0001579) |
1.1 | 2.2 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
1.1 | 5.5 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
1.1 | 4.4 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
1.1 | 4.3 | GO:0097274 | urea homeostasis(GO:0097274) |
1.1 | 32.4 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
1.1 | 10.7 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
1.1 | 2.1 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
1.1 | 21.3 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
1.1 | 19.1 | GO:0002931 | response to ischemia(GO:0002931) |
1.1 | 14.9 | GO:0090177 | establishment of planar polarity involved in neural tube closure(GO:0090177) |
1.1 | 7.4 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
1.1 | 6.3 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
1.1 | 6.3 | GO:1901629 | regulation of presynaptic membrane organization(GO:1901629) |
1.1 | 3.2 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
1.1 | 1.1 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
1.1 | 10.5 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
1.0 | 5.2 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
1.0 | 2.1 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
1.0 | 11.4 | GO:0048102 | autophagic cell death(GO:0048102) |
1.0 | 9.3 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
1.0 | 5.2 | GO:0035989 | tendon development(GO:0035989) |
1.0 | 1.0 | GO:0032328 | alanine transport(GO:0032328) |
1.0 | 2.1 | GO:0090493 | catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
1.0 | 3.1 | GO:0033577 | protein glycosylation in endoplasmic reticulum(GO:0033577) |
1.0 | 6.2 | GO:0097167 | circadian regulation of translation(GO:0097167) |
1.0 | 3.1 | GO:0060134 | prepulse inhibition(GO:0060134) |
1.0 | 4.1 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
1.0 | 4.1 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
1.0 | 2.0 | GO:0090427 | activation of meiosis(GO:0090427) |
1.0 | 29.3 | GO:0045761 | regulation of adenylate cyclase activity(GO:0045761) |
1.0 | 1.0 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
1.0 | 10.0 | GO:0022401 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
1.0 | 6.0 | GO:0032423 | regulation of mismatch repair(GO:0032423) |
1.0 | 9.9 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
1.0 | 1.0 | GO:2001023 | regulation of response to drug(GO:2001023) |
1.0 | 3.0 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
1.0 | 1.0 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
1.0 | 3.0 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
1.0 | 4.9 | GO:0072368 | regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter(GO:0072368) |
1.0 | 46.1 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
1.0 | 5.9 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
1.0 | 2.9 | GO:0021666 | rhombomere formation(GO:0021594) rhombomere 3 formation(GO:0021660) rhombomere 5 morphogenesis(GO:0021664) rhombomere 5 formation(GO:0021666) |
1.0 | 44.3 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
1.0 | 10.5 | GO:0042756 | drinking behavior(GO:0042756) |
1.0 | 2.9 | GO:0015705 | iodide transport(GO:0015705) |
1.0 | 4.8 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.9 | 1.9 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.9 | 0.9 | GO:0099630 | postsynaptic neurotransmitter receptor cycle(GO:0099630) |
0.9 | 6.6 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.9 | 1.9 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
0.9 | 4.7 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
0.9 | 9.4 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.9 | 3.7 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.9 | 10.2 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.9 | 6.5 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.9 | 3.7 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.9 | 4.6 | GO:0048670 | regulation of collateral sprouting(GO:0048670) |
0.9 | 1.8 | GO:0075136 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to immune response of other organism involved in symbiotic interaction(GO:0052564) response to host immune response(GO:0052572) response to host(GO:0075136) |
0.9 | 2.8 | GO:0051030 | snRNA transport(GO:0051030) |
0.9 | 8.3 | GO:0015671 | oxygen transport(GO:0015671) |
0.9 | 1.8 | GO:0007097 | nuclear migration(GO:0007097) establishment of nucleus localization(GO:0040023) |
0.9 | 2.7 | GO:0006499 | N-terminal protein lipidation(GO:0006498) N-terminal protein myristoylation(GO:0006499) N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
0.9 | 6.4 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.9 | 5.4 | GO:0070343 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
0.9 | 121.7 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.9 | 3.6 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.9 | 6.3 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.9 | 9.0 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.9 | 1.8 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) serotonin receptor signaling pathway(GO:0007210) |
0.9 | 3.6 | GO:2000016 | negative regulation of determination of dorsal identity(GO:2000016) |
0.9 | 3.6 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.9 | 2.7 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.9 | 1.8 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.9 | 6.2 | GO:0001757 | somite specification(GO:0001757) |
0.9 | 9.7 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.9 | 5.3 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.9 | 9.6 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.9 | 0.9 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.9 | 5.2 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.9 | 2.6 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.9 | 6.0 | GO:0022028 | tangential migration from the subventricular zone to the olfactory bulb(GO:0022028) |
0.9 | 6.9 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.9 | 6.9 | GO:0003011 | involuntary skeletal muscle contraction(GO:0003011) |
0.9 | 2.6 | GO:0003245 | cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
0.9 | 0.9 | GO:1990379 | lipid transport across blood brain barrier(GO:1990379) |
0.9 | 5.1 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.8 | 3.4 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.8 | 22.9 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.8 | 9.3 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
0.8 | 0.8 | GO:0043465 | regulation of fermentation(GO:0043465) |
0.8 | 0.8 | GO:0051542 | elastin biosynthetic process(GO:0051542) |
0.8 | 0.8 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.8 | 7.5 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.8 | 4.2 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
0.8 | 7.5 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.8 | 1.7 | GO:0046607 | positive regulation of centrosome duplication(GO:0010825) positive regulation of centrosome cycle(GO:0046607) |
0.8 | 0.8 | GO:0051589 | negative regulation of neurotransmitter transport(GO:0051589) |
0.8 | 15.7 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.8 | 2.5 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.8 | 20.5 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.8 | 10.6 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.8 | 46.1 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.8 | 2.4 | GO:0070376 | regulation of ERK5 cascade(GO:0070376) |
0.8 | 3.2 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
0.8 | 10.4 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.8 | 7.9 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.8 | 9.5 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.8 | 2.4 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
0.8 | 18.2 | GO:0007215 | glutamate receptor signaling pathway(GO:0007215) |
0.8 | 0.8 | GO:0048069 | eye pigmentation(GO:0048069) |
0.8 | 1.6 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.8 | 6.3 | GO:0021794 | thalamus development(GO:0021794) |
0.8 | 7.8 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.8 | 3.9 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
0.8 | 0.8 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.8 | 0.8 | GO:0060166 | olfactory pit development(GO:0060166) |
0.8 | 16.4 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
0.8 | 2.3 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.8 | 18.7 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
0.8 | 0.8 | GO:0009301 | snRNA transcription(GO:0009301) |
0.8 | 18.7 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.8 | 7.8 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.8 | 15.5 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.8 | 4.6 | GO:0098703 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
0.8 | 3.1 | GO:0072218 | ascending thin limb development(GO:0072021) thick ascending limb development(GO:0072023) metanephric ascending thin limb development(GO:0072218) metanephric thick ascending limb development(GO:0072233) |
0.8 | 10.0 | GO:0006751 | glutathione catabolic process(GO:0006751) |
0.8 | 3.8 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.8 | 29.1 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.8 | 12.1 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.8 | 4.5 | GO:0015817 | histidine transport(GO:0015817) |
0.8 | 2.3 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
0.7 | 4.5 | GO:1904779 | regulation of protein localization to centrosome(GO:1904779) positive regulation of protein localization to centrosome(GO:1904781) |
0.7 | 3.0 | GO:2000588 | positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
0.7 | 0.7 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
0.7 | 5.2 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
0.7 | 3.0 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.7 | 1.5 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
0.7 | 4.5 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.7 | 4.4 | GO:0014047 | glutamate secretion(GO:0014047) |
0.7 | 1.5 | GO:0090035 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
0.7 | 6.6 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.7 | 2.9 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.7 | 3.7 | GO:0070829 | heterochromatin maintenance(GO:0070829) |
0.7 | 0.7 | GO:0002276 | basophil activation involved in immune response(GO:0002276) |
0.7 | 0.7 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.7 | 3.6 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
0.7 | 1.4 | GO:0031554 | regulation of DNA-templated transcription, termination(GO:0031554) |
0.7 | 7.2 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.7 | 3.6 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.7 | 4.2 | GO:0051459 | regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.7 | 16.9 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.7 | 14.1 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.7 | 3.5 | GO:0038032 | termination of G-protein coupled receptor signaling pathway(GO:0038032) |
0.7 | 3.5 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.7 | 4.9 | GO:0051541 | elastin metabolic process(GO:0051541) elastin catabolic process(GO:0060309) |
0.7 | 3.5 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.7 | 1.4 | GO:0006154 | adenosine catabolic process(GO:0006154) |
0.7 | 6.9 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.7 | 4.1 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
0.7 | 0.7 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.7 | 4.8 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.7 | 4.1 | GO:0034184 | positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.7 | 2.0 | GO:0015688 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
0.7 | 0.7 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) negative regulation of early endosome to late endosome transport(GO:2000642) |
0.7 | 2.0 | GO:0006233 | dTDP biosynthetic process(GO:0006233) dTDP metabolic process(GO:0046072) |
0.7 | 2.7 | GO:0045842 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.7 | 1.4 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.7 | 14.9 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.7 | 4.7 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.7 | 2.7 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
0.7 | 2.7 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
0.7 | 10.1 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.7 | 2.7 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.7 | 5.3 | GO:0033227 | dsRNA transport(GO:0033227) |
0.7 | 5.3 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.7 | 3.3 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
0.7 | 18.5 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.7 | 0.7 | GO:0043201 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.7 | 3.9 | GO:0097354 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.7 | 5.2 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.7 | 1.3 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
0.6 | 1.9 | GO:0031990 | mRNA export from nucleus in response to heat stress(GO:0031990) |
0.6 | 3.2 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
0.6 | 4.5 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.6 | 1.9 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.6 | 0.6 | GO:0042045 | epithelial fluid transport(GO:0042045) |
0.6 | 8.4 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.6 | 2.6 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.6 | 1.9 | GO:1903059 | regulation of protein lipidation(GO:1903059) positive regulation of protein lipidation(GO:1903061) |
0.6 | 8.9 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
0.6 | 2.5 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.6 | 1.3 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
0.6 | 5.6 | GO:0030578 | PML body organization(GO:0030578) |
0.6 | 6.2 | GO:0021842 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
0.6 | 0.6 | GO:0042376 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.6 | 4.3 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.6 | 2.5 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.6 | 7.4 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) |
0.6 | 1.2 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.6 | 4.3 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.6 | 4.9 | GO:2001223 | negative regulation of neuron migration(GO:2001223) |
0.6 | 4.9 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.6 | 1.8 | GO:0016598 | protein arginylation(GO:0016598) |
0.6 | 4.8 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.6 | 4.2 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.6 | 15.5 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.6 | 5.4 | GO:0006903 | vesicle targeting(GO:0006903) |
0.6 | 3.0 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.6 | 3.6 | GO:0030035 | microspike assembly(GO:0030035) |
0.6 | 4.2 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.6 | 1.8 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.6 | 2.4 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
0.6 | 2.4 | GO:0046381 | CMP-N-acetylneuraminate metabolic process(GO:0046381) |
0.6 | 1.8 | GO:0030961 | peptidyl-arginine hydroxylation(GO:0030961) |
0.6 | 1.2 | GO:0018312 | peptidyl-serine ADP-ribosylation(GO:0018312) |
0.6 | 0.6 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.6 | 1.8 | GO:0036079 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
0.6 | 2.9 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.6 | 10.8 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.6 | 3.4 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.6 | 1.1 | GO:0036215 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.6 | 4.0 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
0.6 | 29.5 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.6 | 2.8 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.6 | 1.7 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.6 | 1.1 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.6 | 1.1 | GO:0072103 | renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
0.6 | 7.3 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.6 | 3.3 | GO:0048298 | positive regulation of isotype switching to IgA isotypes(GO:0048298) |
0.6 | 3.9 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.6 | 13.3 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.6 | 5.5 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.5 | 1.6 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.5 | 1.1 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.5 | 0.5 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.5 | 2.2 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.5 | 4.3 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.5 | 1.1 | GO:0061621 | NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
0.5 | 3.2 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
0.5 | 1.6 | GO:0090148 | membrane fission(GO:0090148) |
0.5 | 5.4 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.5 | 2.1 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.5 | 4.8 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.5 | 1.6 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.5 | 11.1 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.5 | 6.3 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.5 | 5.3 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.5 | 13.1 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.5 | 1.0 | GO:0036166 | phenotypic switching(GO:0036166) cellular response to cocaine(GO:0071314) |
0.5 | 1.0 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.5 | 1.5 | GO:2001201 | regulation of transforming growth factor-beta secretion(GO:2001201) |
0.5 | 43.0 | GO:0035308 | negative regulation of protein dephosphorylation(GO:0035308) |
0.5 | 8.2 | GO:0034063 | stress granule assembly(GO:0034063) |
0.5 | 1.0 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.5 | 2.0 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.5 | 1.5 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.5 | 2.0 | GO:2000347 | positive regulation of hepatocyte proliferation(GO:2000347) |
0.5 | 1.5 | GO:0040010 | positive regulation of growth rate(GO:0040010) |
0.5 | 0.5 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.5 | 7.5 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.5 | 0.5 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.5 | 25.9 | GO:0098840 | protein transport along microtubule(GO:0098840) |
0.5 | 3.0 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.5 | 1.5 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.5 | 0.5 | GO:0044830 | modulation by host of viral RNA genome replication(GO:0044830) |
0.5 | 2.5 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.5 | 0.5 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.5 | 3.4 | GO:0030705 | cytoskeleton-dependent intracellular transport(GO:0030705) |
0.5 | 0.5 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.5 | 1.5 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.5 | 1.0 | GO:0046075 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.5 | 1.5 | GO:0015966 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
0.5 | 55.0 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.5 | 5.8 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.5 | 5.8 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.5 | 0.5 | GO:0018201 | peptidyl-glycine modification(GO:0018201) |
0.5 | 2.4 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.5 | 1.9 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.5 | 0.5 | GO:0046101 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.5 | 7.1 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.5 | 1.0 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.5 | 1.4 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.5 | 1.4 | GO:0035638 | patched ligand maturation(GO:0007225) signal maturation(GO:0035638) |
0.5 | 15.1 | GO:0015991 | ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.5 | 7.5 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.5 | 8.8 | GO:0032456 | endocytic recycling(GO:0032456) |
0.5 | 5.6 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) |
0.5 | 0.9 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.5 | 5.5 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.5 | 19.3 | GO:0007612 | learning(GO:0007612) |
0.5 | 0.9 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.5 | 9.1 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.5 | 2.7 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.5 | 4.5 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.5 | 1.8 | GO:1904247 | positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
0.4 | 0.9 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.4 | 4.5 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.4 | 0.9 | GO:0036233 | glycine import(GO:0036233) |
0.4 | 2.2 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
0.4 | 3.1 | GO:0033031 | regulation of neutrophil apoptotic process(GO:0033029) positive regulation of neutrophil apoptotic process(GO:0033031) |
0.4 | 1.8 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.4 | 0.9 | GO:0097502 | mannosylation(GO:0097502) |
0.4 | 5.3 | GO:0072384 | organelle transport along microtubule(GO:0072384) |
0.4 | 4.4 | GO:0046549 | retinal cone cell development(GO:0046549) |
0.4 | 30.7 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.4 | 3.5 | GO:0009098 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
0.4 | 1.3 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
0.4 | 1.7 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.4 | 2.6 | GO:0048520 | positive regulation of behavior(GO:0048520) |
0.4 | 5.6 | GO:0042428 | serotonin metabolic process(GO:0042428) |
0.4 | 2.1 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.4 | 1.3 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.4 | 1.3 | GO:0072553 | terminal button organization(GO:0072553) |
0.4 | 1.3 | GO:0016131 | brassinosteroid metabolic process(GO:0016131) brassinosteroid biosynthetic process(GO:0016132) |
0.4 | 5.1 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.4 | 0.8 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
0.4 | 1.3 | GO:0051710 | regulation of cytolysis in other organism(GO:0051710) positive regulation of cytolysis in other organism(GO:0051714) |
0.4 | 0.8 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.4 | 7.5 | GO:0000338 | protein deneddylation(GO:0000338) |
0.4 | 4.6 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.4 | 5.4 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.4 | 1.2 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.4 | 0.8 | GO:0090399 | replicative senescence(GO:0090399) |
0.4 | 1.2 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
0.4 | 6.2 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.4 | 5.0 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
0.4 | 0.4 | GO:0071042 | nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
0.4 | 0.8 | GO:0048822 | enucleate erythrocyte development(GO:0048822) |
0.4 | 2.1 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.4 | 0.8 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
0.4 | 4.0 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.4 | 0.8 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.4 | 1.2 | GO:0042982 | amyloid precursor protein metabolic process(GO:0042982) |
0.4 | 6.0 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.4 | 1.6 | GO:0022410 | circadian sleep/wake cycle process(GO:0022410) circadian sleep/wake cycle, sleep(GO:0050802) |
0.4 | 7.1 | GO:0060004 | reflex(GO:0060004) |
0.4 | 9.9 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.4 | 1.2 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
0.4 | 1.2 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.4 | 1.2 | GO:1903659 | transforming growth factor beta activation(GO:0036363) regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.4 | 1.2 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.4 | 2.7 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.4 | 16.4 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.4 | 2.7 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.4 | 1.1 | GO:2001212 | regulation of vasculogenesis(GO:2001212) |
0.4 | 0.4 | GO:1904959 | regulation of cytochrome-c oxidase activity(GO:1904959) |
0.4 | 1.9 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.4 | 1.5 | GO:0015904 | tetracycline transport(GO:0015904) |
0.4 | 2.6 | GO:0060979 | vasculogenesis involved in coronary vascular morphogenesis(GO:0060979) |
0.4 | 2.6 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.4 | 2.6 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.4 | 2.2 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.4 | 5.9 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.4 | 2.2 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.4 | 6.6 | GO:0006828 | manganese ion transport(GO:0006828) |
0.4 | 1.5 | GO:0071625 | vocalization behavior(GO:0071625) |
0.4 | 0.4 | GO:0042275 | error-free postreplication DNA repair(GO:0042275) |
0.4 | 2.2 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.4 | 1.4 | GO:0080009 | mRNA methylation(GO:0080009) |
0.4 | 0.4 | GO:0033483 | gas homeostasis(GO:0033483) |
0.4 | 3.9 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.4 | 1.1 | GO:0033082 | regulation of extrathymic T cell differentiation(GO:0033082) |
0.4 | 9.2 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.4 | 1.4 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.4 | 6.7 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.4 | 2.1 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.3 | 2.1 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.3 | 1.0 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.3 | 1.4 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.3 | 0.3 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
0.3 | 1.0 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.3 | 1.4 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.3 | 2.0 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.3 | 2.0 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.3 | 9.2 | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
0.3 | 1.0 | GO:0032298 | positive regulation of DNA-dependent DNA replication initiation(GO:0032298) |
0.3 | 3.0 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
0.3 | 1.3 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
0.3 | 0.3 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
0.3 | 1.3 | GO:0072402 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
0.3 | 4.0 | GO:2000232 | regulation of rRNA processing(GO:2000232) |
0.3 | 4.3 | GO:0038179 | neurotrophin signaling pathway(GO:0038179) |
0.3 | 1.6 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.3 | 8.4 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.3 | 3.6 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.3 | 2.6 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
0.3 | 2.6 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
0.3 | 2.2 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.3 | 0.9 | GO:0009107 | lipoate biosynthetic process(GO:0009107) |
0.3 | 1.2 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.3 | 0.6 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.3 | 0.3 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
0.3 | 0.9 | GO:0048254 | snoRNA localization(GO:0048254) |
0.3 | 5.9 | GO:0006171 | cAMP biosynthetic process(GO:0006171) |
0.3 | 2.5 | GO:0021696 | cerebellar cortex morphogenesis(GO:0021696) |
0.3 | 0.3 | GO:1901524 | regulation of macromitophagy(GO:1901524) positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
0.3 | 0.9 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) negative regulation of entry of bacterium into host cell(GO:2000536) |
0.3 | 2.7 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.3 | 3.0 | GO:0032264 | IMP salvage(GO:0032264) |
0.3 | 1.2 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.3 | 1.2 | GO:1902269 | positive regulation of polyamine transmembrane transport(GO:1902269) |
0.3 | 14.5 | GO:0045214 | sarcomere organization(GO:0045214) |
0.3 | 5.9 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.3 | 0.3 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.3 | 1.2 | GO:0051182 | coenzyme transport(GO:0051182) |
0.3 | 0.9 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.3 | 2.3 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.3 | 25.3 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) |
0.3 | 0.9 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
0.3 | 0.6 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.3 | 0.9 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.3 | 1.4 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.3 | 1.1 | GO:0038016 | insulin receptor internalization(GO:0038016) |
0.3 | 1.1 | GO:0060026 | convergent extension(GO:0060026) |
0.3 | 0.6 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.3 | 0.6 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.3 | 0.6 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.3 | 0.6 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.3 | 1.4 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.3 | 1.9 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.3 | 0.8 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.3 | 8.7 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.3 | 2.2 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.3 | 11.4 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.3 | 0.8 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.3 | 0.8 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.3 | 0.8 | GO:0070625 | zymogen granule exocytosis(GO:0070625) |
0.3 | 0.8 | GO:0009397 | 10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
0.3 | 0.8 | GO:0002946 | tRNA C5-cytosine methylation(GO:0002946) |
0.3 | 3.9 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.3 | 1.6 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.3 | 1.1 | GO:0051316 | attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation(GO:0051316) |
0.3 | 2.1 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.3 | 1.3 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
0.3 | 2.3 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.3 | 3.4 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.3 | 2.9 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.3 | 0.8 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.3 | 0.5 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.3 | 1.6 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
0.3 | 5.4 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.3 | 0.8 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) positive regulation of aminoacyl-tRNA ligase activity(GO:1903632) |
0.3 | 7.9 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.3 | 0.8 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.3 | 0.5 | GO:0048478 | replication fork protection(GO:0048478) |
0.3 | 1.8 | GO:0090042 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
0.3 | 0.8 | GO:0010705 | meiotic DNA double-strand break processing involved in reciprocal meiotic recombination(GO:0010705) |
0.3 | 21.3 | GO:0030010 | establishment of cell polarity(GO:0030010) |
0.3 | 6.6 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.3 | 0.3 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.2 | 5.2 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.2 | 0.5 | GO:0099627 | neurotransmitter receptor cycle(GO:0099627) |
0.2 | 0.2 | GO:0090330 | regulation of platelet aggregation(GO:0090330) |
0.2 | 2.2 | GO:0043482 | pigment accumulation(GO:0043476) cellular pigment accumulation(GO:0043482) |
0.2 | 0.2 | GO:0033684 | regulation of luteinizing hormone secretion(GO:0033684) positive regulation of luteinizing hormone secretion(GO:0033686) |
0.2 | 0.7 | GO:0035973 | aggrephagy(GO:0035973) |
0.2 | 0.7 | GO:0001869 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
0.2 | 3.6 | GO:0002347 | response to tumor cell(GO:0002347) |
0.2 | 1.0 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.2 | 0.7 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.2 | 3.1 | GO:0051014 | actin filament severing(GO:0051014) |
0.2 | 0.7 | GO:1901679 | nucleotide transmembrane transport(GO:1901679) |
0.2 | 4.8 | GO:0072010 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.2 | 1.0 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.2 | 3.8 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.2 | 0.5 | GO:1904328 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
0.2 | 0.9 | GO:1902267 | polyamine transport(GO:0015846) polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) negative regulation of polyamine transmembrane transport(GO:1902268) |
0.2 | 7.3 | GO:0031623 | receptor internalization(GO:0031623) |
0.2 | 0.7 | GO:0036509 | trimming of terminal mannose on B branch(GO:0036509) |
0.2 | 2.1 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.2 | 0.9 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.2 | 1.4 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.2 | 4.2 | GO:0051642 | centrosome localization(GO:0051642) |
0.2 | 0.5 | GO:0014877 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.2 | 1.2 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.2 | 1.4 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.2 | 2.5 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.2 | 0.5 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.2 | 3.0 | GO:0009148 | pyrimidine nucleoside triphosphate biosynthetic process(GO:0009148) |
0.2 | 8.4 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.2 | 0.5 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.2 | 0.2 | GO:0051293 | establishment of spindle localization(GO:0051293) |
0.2 | 1.1 | GO:0009227 | nucleotide-sugar catabolic process(GO:0009227) |
0.2 | 0.2 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.2 | 0.7 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
0.2 | 1.1 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.2 | 0.7 | GO:0032077 | positive regulation of deoxyribonuclease activity(GO:0032077) |
0.2 | 5.7 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.2 | 6.8 | GO:0019835 | cytolysis(GO:0019835) |
0.2 | 5.7 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.2 | 4.2 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.2 | 1.5 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.2 | 1.7 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.2 | 17.6 | GO:0006821 | chloride transport(GO:0006821) |
0.2 | 0.4 | GO:0090367 | negative regulation of mRNA modification(GO:0090367) |
0.2 | 5.2 | GO:0050804 | modulation of synaptic transmission(GO:0050804) |
0.2 | 3.9 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
0.2 | 0.9 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.2 | 1.1 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.2 | 0.9 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.2 | 0.8 | GO:0019086 | late viral transcription(GO:0019086) |
0.2 | 0.8 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.2 | 0.8 | GO:0045338 | farnesyl diphosphate metabolic process(GO:0045338) |
0.2 | 0.8 | GO:0000390 | spliceosomal complex disassembly(GO:0000390) |
0.2 | 1.0 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.2 | 6.7 | GO:0006813 | potassium ion transport(GO:0006813) |
0.2 | 0.4 | GO:0031645 | negative regulation of neurological system process(GO:0031645) |
0.2 | 3.1 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.2 | 1.0 | GO:0009452 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.2 | 0.8 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.2 | 1.2 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.2 | 3.0 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
0.2 | 2.7 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.2 | 0.4 | GO:0097479 | synaptic vesicle localization(GO:0097479) |
0.2 | 1.4 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.2 | 3.1 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.2 | 1.9 | GO:0007614 | short-term memory(GO:0007614) |
0.2 | 0.4 | GO:0036245 | cellular response to menadione(GO:0036245) |
0.2 | 0.4 | GO:2000819 | regulation of nucleotide-excision repair(GO:2000819) |
0.2 | 1.1 | GO:1903755 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
0.2 | 1.5 | GO:0036337 | Fas signaling pathway(GO:0036337) |
0.2 | 10.7 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.2 | 0.7 | GO:0000105 | histidine biosynthetic process(GO:0000105) |
0.2 | 0.6 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.2 | 0.4 | GO:0017126 | nucleologenesis(GO:0017126) |
0.2 | 4.7 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.2 | 3.6 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
0.2 | 1.1 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.2 | 0.2 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.2 | 0.5 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.2 | 0.7 | GO:0048105 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
0.2 | 1.8 | GO:0036065 | fucosylation(GO:0036065) |
0.2 | 0.5 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.2 | 0.5 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.2 | 0.9 | GO:1904754 | positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
0.2 | 0.3 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.2 | 0.7 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.2 | 0.9 | GO:0044727 | DNA demethylation of male pronucleus(GO:0044727) |
0.2 | 0.5 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) determination of dorsal identity(GO:0048263) |
0.2 | 0.5 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.2 | 4.1 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
0.2 | 0.2 | GO:0021932 | hindbrain radial glia guided cell migration(GO:0021932) formation of radial glial scaffolds(GO:0021943) |
0.2 | 2.5 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.2 | 6.9 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.2 | 3.0 | GO:0001881 | receptor recycling(GO:0001881) |
0.2 | 0.2 | GO:1904954 | canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904954) |
0.2 | 1.3 | GO:0035176 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.2 | 0.7 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.2 | 2.3 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.2 | 1.8 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.2 | 0.8 | GO:2001168 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.2 | 0.3 | GO:0098779 | mitophagy in response to mitochondrial depolarization(GO:0098779) |
0.2 | 0.6 | GO:0043418 | homocysteine catabolic process(GO:0043418) |
0.2 | 1.4 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.2 | 0.5 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.2 | 2.8 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.2 | 0.9 | GO:1902116 | negative regulation of organelle assembly(GO:1902116) |
0.2 | 1.7 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.1 | 1.0 | GO:0014887 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.1 | 0.1 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.1 | 14.2 | GO:0000077 | DNA damage checkpoint(GO:0000077) |
0.1 | 4.8 | GO:0032418 | lysosome localization(GO:0032418) |
0.1 | 0.7 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.1 | 0.1 | GO:1902563 | regulation of neutrophil degranulation(GO:0043313) regulation of neutrophil activation(GO:1902563) |
0.1 | 0.1 | GO:2000313 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.1 | 0.4 | GO:0043519 | myosin II filament organization(GO:0031038) regulation of myosin II filament organization(GO:0043519) |
0.1 | 1.8 | GO:0050718 | positive regulation of interleukin-1 secretion(GO:0050716) positive regulation of interleukin-1 beta secretion(GO:0050718) |
0.1 | 0.3 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.1 | 1.0 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.1 | 0.7 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 1.2 | GO:0071816 | tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.1 | 0.4 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.1 | 0.5 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.1 | 0.4 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
0.1 | 1.8 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.1 | 3.7 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.1 | 0.1 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.1 | 0.5 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.1 | 0.9 | GO:0010517 | regulation of phospholipase activity(GO:0010517) |
0.1 | 4.3 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.1 | 0.4 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.1 | 0.5 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.1 | 0.1 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.1 | 0.8 | GO:2000345 | regulation of hepatocyte proliferation(GO:2000345) |
0.1 | 1.1 | GO:0051601 | exocyst localization(GO:0051601) |
0.1 | 0.5 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.1 | 1.8 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.1 | 0.1 | GO:0097037 | heme export(GO:0097037) |
0.1 | 0.2 | GO:0051013 | microtubule severing(GO:0051013) |
0.1 | 1.1 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.1 | 0.6 | GO:0001505 | regulation of neurotransmitter levels(GO:0001505) |
0.1 | 39.3 | GO:0007264 | small GTPase mediated signal transduction(GO:0007264) |
0.1 | 0.7 | GO:0008593 | regulation of Notch signaling pathway(GO:0008593) |
0.1 | 1.7 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.1 | 0.4 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.1 | 1.2 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.1 | 0.5 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.1 | 0.3 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 0.6 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
0.1 | 0.9 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.1 | 1.6 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 0.3 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.1 | 1.5 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.1 | 1.2 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.1 | 0.4 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.1 | 2.0 | GO:0007416 | synapse assembly(GO:0007416) |
0.1 | 0.4 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.1 | 1.6 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.1 | 0.4 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.1 | 6.9 | GO:0007018 | microtubule-based movement(GO:0007018) |
0.1 | 0.6 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.1 | 0.6 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.1 | 1.0 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 0.3 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.1 | 0.3 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.1 | 0.3 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
0.1 | 0.2 | GO:0031392 | regulation of prostaglandin biosynthetic process(GO:0031392) positive regulation of prostaglandin biosynthetic process(GO:0031394) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.1 | 0.3 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.1 | 0.1 | GO:0001999 | renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure(GO:0001999) renin secretion into blood stream(GO:0002001) regulation of renin secretion into blood stream(GO:1900133) positive regulation of renin secretion into blood stream(GO:1900135) |
0.1 | 0.7 | GO:1904377 | positive regulation of protein localization to cell periphery(GO:1904377) |
0.1 | 10.9 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.1 | 1.3 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.1 | 0.3 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
0.1 | 0.2 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.1 | 1.3 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.1 | 2.2 | GO:0000154 | rRNA modification(GO:0000154) |
0.1 | 0.2 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.1 | 1.0 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.1 | 1.3 | GO:0045921 | positive regulation of exocytosis(GO:0045921) |
0.1 | 1.3 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.1 | 0.8 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.1 | 0.4 | GO:0031296 | B cell costimulation(GO:0031296) |
0.1 | 0.7 | GO:0032733 | positive regulation of interleukin-10 production(GO:0032733) |
0.1 | 0.7 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.1 | 0.4 | GO:0072711 | cellular response to hydroxyurea(GO:0072711) |
0.1 | 0.1 | GO:1905146 | lysosomal protein catabolic process(GO:1905146) |
0.1 | 0.8 | GO:0016045 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.1 | 0.9 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.1 | 0.4 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
0.1 | 1.3 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
0.1 | 0.5 | GO:0051647 | nucleus localization(GO:0051647) |
0.1 | 0.1 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
0.1 | 0.5 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.1 | 0.1 | GO:1901978 | regulation of spindle checkpoint(GO:0090231) positive regulation of spindle checkpoint(GO:0090232) regulation of cell cycle checkpoint(GO:1901976) positive regulation of cell cycle checkpoint(GO:1901978) |
0.1 | 0.7 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.1 | 0.3 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 1.8 | GO:0030307 | positive regulation of cell growth(GO:0030307) |
0.1 | 0.3 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.1 | 0.1 | GO:0000448 | cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000448) |
0.1 | 1.3 | GO:0006744 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) |
0.1 | 0.4 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.1 | 0.1 | GO:0098780 | response to mitochondrial depolarisation(GO:0098780) |
0.1 | 4.1 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.1 | 0.3 | GO:1900040 | regulation of interleukin-2 secretion(GO:1900040) |
0.1 | 0.2 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.1 | 0.3 | GO:0009624 | response to nematode(GO:0009624) |
0.1 | 1.3 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.1 | 0.9 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.1 | 0.1 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.1 | 0.3 | GO:0071107 | response to parathyroid hormone(GO:0071107) |
0.1 | 0.2 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
0.1 | 0.5 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.0 | 0.0 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.0 | 0.2 | GO:0015889 | cobalamin transport(GO:0015889) |
0.0 | 0.1 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.0 | 0.1 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.0 | 0.1 | GO:0035247 | peptidyl-arginine omega-N-methylation(GO:0035247) |
0.0 | 0.3 | GO:2001205 | negative regulation of osteoclast development(GO:2001205) |
0.0 | 0.4 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.0 | 1.2 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.0 | 0.1 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.0 | 0.1 | GO:0098501 | polynucleotide dephosphorylation(GO:0098501) |
0.0 | 0.4 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.0 | 1.1 | GO:0046677 | response to antibiotic(GO:0046677) |
0.0 | 1.6 | GO:0051306 | mitotic sister chromatid separation(GO:0051306) |
0.0 | 5.5 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.4 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.3 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.4 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.0 | 0.1 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.0 | 0.2 | GO:0001550 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
0.0 | 0.4 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.0 | 0.1 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.0 | 0.1 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
0.0 | 0.1 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.0 | 0.1 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.0 | 0.6 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.0 | 0.1 | GO:0015886 | heme transport(GO:0015886) |
0.0 | 0.1 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.0 | 0.1 | GO:1904253 | positive regulation of bile acid biosynthetic process(GO:0070859) positive regulation of bile acid metabolic process(GO:1904253) |
0.0 | 0.1 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
0.0 | 0.2 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.0 | 0.1 | GO:0010447 | response to acidic pH(GO:0010447) |
0.0 | 0.1 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.0 | 0.5 | GO:0050832 | defense response to fungus(GO:0050832) |
0.0 | 0.1 | GO:0048570 | notochord morphogenesis(GO:0048570) |
0.0 | 0.1 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.0 | 0.1 | GO:0071569 | protein ufmylation(GO:0071569) |
0.0 | 0.1 | GO:0007032 | endosome organization(GO:0007032) |
0.0 | 0.0 | GO:1904528 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) positive regulation of microtubule binding(GO:1904528) |
0.0 | 0.1 | GO:1904357 | negative regulation of telomere maintenance via telomere lengthening(GO:1904357) |
0.0 | 0.1 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.0 | 0.0 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
0.0 | 0.2 | GO:0015693 | magnesium ion transport(GO:0015693) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
11.0 | 33.1 | GO:0098855 | HCN channel complex(GO:0098855) |
9.0 | 26.9 | GO:0098830 | presynaptic endosome(GO:0098830) |
8.3 | 16.6 | GO:0044305 | calyx of Held(GO:0044305) |
8.1 | 8.1 | GO:1902737 | dendritic filopodium(GO:1902737) |
6.9 | 27.7 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
6.8 | 27.1 | GO:0042642 | actomyosin, myosin complex part(GO:0042642) |
6.5 | 32.4 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
6.1 | 30.7 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
5.9 | 17.6 | GO:1990257 | piccolo-bassoon transport vesicle(GO:1990257) |
5.8 | 87.1 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
5.7 | 62.2 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
5.4 | 27.1 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
5.3 | 26.5 | GO:0044316 | cone cell pedicle(GO:0044316) |
5.3 | 79.5 | GO:0044327 | dendritic spine head(GO:0044327) |
4.9 | 128.6 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
4.9 | 246.2 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
4.7 | 14.1 | GO:0014801 | longitudinal sarcoplasmic reticulum(GO:0014801) |
4.6 | 32.4 | GO:0005955 | calcineurin complex(GO:0005955) |
4.6 | 45.7 | GO:0032279 | asymmetric synapse(GO:0032279) |
4.5 | 67.1 | GO:0031209 | SCAR complex(GO:0031209) |
4.4 | 8.8 | GO:1990769 | proximal neuron projection(GO:1990769) |
4.2 | 25.4 | GO:0032591 | dendritic spine membrane(GO:0032591) |
4.2 | 164.7 | GO:0043194 | axon initial segment(GO:0043194) |
4.2 | 201.7 | GO:0048786 | presynaptic active zone(GO:0048786) |
3.9 | 38.6 | GO:0043083 | synaptic cleft(GO:0043083) |
3.8 | 57.5 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
3.7 | 11.2 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
3.7 | 70.0 | GO:0035253 | ciliary rootlet(GO:0035253) |
3.4 | 51.6 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
3.4 | 10.2 | GO:1990031 | pinceau fiber(GO:1990031) |
3.4 | 17.0 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
3.4 | 47.5 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
3.3 | 320.1 | GO:0043198 | dendritic shaft(GO:0043198) |
3.3 | 3.3 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
3.3 | 9.8 | GO:1903095 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
3.2 | 12.7 | GO:0072534 | perineuronal net(GO:0072534) |
3.1 | 15.4 | GO:0061673 | mitotic spindle astral microtubule(GO:0061673) |
3.0 | 78.8 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
3.0 | 9.1 | GO:0044302 | dentate gyrus mossy fiber(GO:0044302) |
3.0 | 14.9 | GO:0044294 | dendritic growth cone(GO:0044294) |
2.8 | 11.1 | GO:0014802 | terminal cisterna(GO:0014802) |
2.8 | 13.9 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
2.7 | 11.0 | GO:0071920 | cleavage body(GO:0071920) |
2.7 | 60.2 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
2.7 | 8.2 | GO:1902912 | pyruvate kinase complex(GO:1902912) |
2.6 | 7.9 | GO:0048179 | activin receptor complex(GO:0048179) |
2.6 | 13.2 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
2.6 | 13.1 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
2.5 | 15.2 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
2.5 | 2.5 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
2.5 | 19.7 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
2.4 | 7.3 | GO:0070985 | TFIIK complex(GO:0070985) |
2.4 | 19.5 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
2.4 | 36.5 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
2.4 | 43.3 | GO:0033270 | paranode region of axon(GO:0033270) |
2.4 | 136.6 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
2.3 | 164.3 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
2.3 | 20.8 | GO:0097427 | microtubule bundle(GO:0097427) |
2.3 | 62.0 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
2.3 | 245.9 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
2.2 | 24.7 | GO:0032009 | early phagosome(GO:0032009) |
2.2 | 19.8 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
2.2 | 4.3 | GO:0032280 | symmetric synapse(GO:0032280) |
2.2 | 4.3 | GO:0008091 | spectrin(GO:0008091) |
2.2 | 21.5 | GO:0005883 | neurofilament(GO:0005883) |
2.1 | 2.1 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
2.0 | 14.3 | GO:0033269 | internode region of axon(GO:0033269) |
2.0 | 3.9 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
1.9 | 615.4 | GO:0014069 | postsynaptic density(GO:0014069) |
1.9 | 17.2 | GO:0098845 | postsynaptic endosome(GO:0098845) |
1.9 | 11.4 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
1.9 | 29.7 | GO:0031045 | dense core granule(GO:0031045) |
1.9 | 275.9 | GO:0008021 | synaptic vesicle(GO:0008021) |
1.8 | 3.7 | GO:0016939 | kinesin II complex(GO:0016939) |
1.8 | 27.5 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
1.8 | 7.3 | GO:1990032 | parallel fiber(GO:1990032) |
1.8 | 92.9 | GO:0042734 | presynaptic membrane(GO:0042734) |
1.8 | 24.9 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
1.7 | 15.3 | GO:0036449 | microtubule minus-end(GO:0036449) |
1.7 | 9.9 | GO:0000235 | astral microtubule(GO:0000235) |
1.6 | 11.5 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
1.6 | 98.5 | GO:0043195 | terminal bouton(GO:0043195) |
1.6 | 35.2 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
1.6 | 4.7 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
1.6 | 4.7 | GO:0090537 | CERF complex(GO:0090537) |
1.5 | 1.5 | GO:0043291 | RAVE complex(GO:0043291) |
1.5 | 36.8 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
1.5 | 13.6 | GO:0030314 | junctional membrane complex(GO:0030314) |
1.5 | 6.1 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
1.5 | 7.4 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
1.5 | 44.5 | GO:0071565 | nBAF complex(GO:0071565) |
1.5 | 19.0 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
1.4 | 8.7 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
1.4 | 17.4 | GO:0032590 | dendrite membrane(GO:0032590) |
1.4 | 1.4 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
1.4 | 14.2 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
1.4 | 88.0 | GO:0034704 | calcium channel complex(GO:0034704) |
1.4 | 36.9 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
1.4 | 5.5 | GO:0097444 | spine apparatus(GO:0097444) |
1.4 | 4.1 | GO:0055028 | cortical microtubule(GO:0055028) |
1.4 | 16.3 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
1.4 | 4.1 | GO:0097635 | extrinsic component of autophagosome membrane(GO:0097635) |
1.4 | 18.9 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
1.3 | 10.6 | GO:0098793 | presynapse(GO:0098793) |
1.3 | 13.1 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
1.3 | 21.8 | GO:0035631 | CD40 receptor complex(GO:0035631) |
1.3 | 3.8 | GO:0044094 | host cell nucleus(GO:0042025) host cell nuclear part(GO:0044094) |
1.3 | 3.8 | GO:0060171 | stereocilium membrane(GO:0060171) |
1.3 | 8.8 | GO:0097165 | nuclear stress granule(GO:0097165) |
1.2 | 21.1 | GO:0000124 | SAGA complex(GO:0000124) |
1.2 | 238.6 | GO:0030426 | growth cone(GO:0030426) |
1.2 | 16.8 | GO:0097449 | astrocyte projection(GO:0097449) |
1.2 | 7.1 | GO:0070449 | elongin complex(GO:0070449) |
1.2 | 22.3 | GO:0060076 | excitatory synapse(GO:0060076) |
1.0 | 3.1 | GO:0030673 | axolemma(GO:0030673) |
1.0 | 9.2 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
1.0 | 152.8 | GO:0045211 | postsynaptic membrane(GO:0045211) |
1.0 | 7.1 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
1.0 | 6.0 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
1.0 | 8.9 | GO:0032433 | filopodium tip(GO:0032433) |
1.0 | 8.8 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
1.0 | 1.9 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
1.0 | 2.9 | GO:1990879 | CST complex(GO:1990879) |
1.0 | 16.3 | GO:0001939 | female pronucleus(GO:0001939) |
0.9 | 7.5 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.9 | 27.0 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.9 | 24.2 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.9 | 19.4 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.9 | 4.6 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.9 | 8.1 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.9 | 12.6 | GO:0016600 | flotillin complex(GO:0016600) |
0.9 | 4.4 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.9 | 57.6 | GO:0043197 | dendritic spine(GO:0043197) |
0.9 | 1.8 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.9 | 9.6 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.9 | 1.7 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.9 | 5.2 | GO:0042583 | chromaffin granule(GO:0042583) |
0.9 | 0.9 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.8 | 180.8 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.8 | 12.7 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.8 | 4.2 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.8 | 38.9 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.8 | 1.7 | GO:0000125 | PCAF complex(GO:0000125) |
0.8 | 3.4 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.8 | 4.8 | GO:1990707 | subtelomeric heterochromatin(GO:1990421) nuclear subtelomeric heterochromatin(GO:1990707) |
0.8 | 22.6 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.8 | 8.0 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.8 | 2.4 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.8 | 2.3 | GO:0097440 | apical dendrite(GO:0097440) |
0.8 | 6.9 | GO:0034709 | methylosome(GO:0034709) |
0.8 | 7.7 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.8 | 2.3 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
0.8 | 19.7 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.7 | 2.2 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.7 | 32.3 | GO:0000139 | Golgi membrane(GO:0000139) |
0.7 | 1.5 | GO:0055087 | Ski complex(GO:0055087) |
0.7 | 12.4 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.7 | 3.6 | GO:0043293 | apoptosome(GO:0043293) |
0.7 | 2.1 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.7 | 2.1 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.7 | 3.5 | GO:0035976 | AP1 complex(GO:0035976) |
0.7 | 63.3 | GO:0043204 | perikaryon(GO:0043204) |
0.7 | 2.0 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.7 | 0.7 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
0.7 | 11.9 | GO:0070938 | contractile ring(GO:0070938) |
0.7 | 6.6 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.7 | 3.9 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.7 | 2.6 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
0.6 | 1.3 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.6 | 10.8 | GO:0042599 | lamellar body(GO:0042599) |
0.6 | 10.7 | GO:0036038 | MKS complex(GO:0036038) |
0.6 | 5.0 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.6 | 1.3 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.6 | 1.2 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.6 | 8.0 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.6 | 3.0 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.6 | 3.0 | GO:0070820 | tertiary granule(GO:0070820) |
0.6 | 6.0 | GO:0000243 | commitment complex(GO:0000243) |
0.6 | 8.4 | GO:0005869 | dynactin complex(GO:0005869) |
0.6 | 16.2 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.6 | 3.5 | GO:0030870 | Mre11 complex(GO:0030870) |
0.6 | 54.9 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.6 | 3.5 | GO:0005683 | U7 snRNP(GO:0005683) |
0.6 | 1.7 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.6 | 4.0 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.6 | 13.5 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.6 | 4.4 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.5 | 2.2 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.5 | 1.1 | GO:0032437 | cuticular plate(GO:0032437) |
0.5 | 2.7 | GO:0000799 | nuclear condensin complex(GO:0000799) |
0.5 | 11.3 | GO:0043034 | costamere(GO:0043034) |
0.5 | 17.1 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.5 | 6.4 | GO:0045180 | basal cortex(GO:0045180) |
0.5 | 1.6 | GO:0070695 | FHF complex(GO:0070695) |
0.5 | 4.2 | GO:0033263 | CORVET complex(GO:0033263) |
0.5 | 11.3 | GO:0001891 | phagocytic cup(GO:0001891) |
0.5 | 3.6 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.5 | 21.0 | GO:0005921 | gap junction(GO:0005921) |
0.5 | 5.1 | GO:0036157 | outer dynein arm(GO:0036157) |
0.5 | 3.0 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.5 | 2.5 | GO:1990745 | EARP complex(GO:1990745) |
0.5 | 41.4 | GO:0055037 | recycling endosome(GO:0055037) |
0.5 | 1.5 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
0.5 | 15.5 | GO:0031901 | early endosome membrane(GO:0031901) |
0.5 | 1.5 | GO:0034455 | t-UTP complex(GO:0034455) |
0.5 | 23.1 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.5 | 9.1 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.5 | 1.0 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.5 | 1.4 | GO:1902560 | GMP reductase complex(GO:1902560) |
0.5 | 1.0 | GO:0043512 | inhibin A complex(GO:0043512) |
0.5 | 38.5 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.5 | 4.2 | GO:0071203 | WASH complex(GO:0071203) |
0.5 | 5.0 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.5 | 3.6 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.4 | 14.8 | GO:0030990 | intraciliary transport particle(GO:0030990) |
0.4 | 2.6 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.4 | 0.4 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.4 | 1.3 | GO:0032545 | CURI complex(GO:0032545) UTP-C complex(GO:0034456) |
0.4 | 1.3 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
0.4 | 1.8 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.4 | 2.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.4 | 14.3 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.4 | 3.5 | GO:0097542 | ciliary tip(GO:0097542) |
0.4 | 1.3 | GO:0097144 | BAX complex(GO:0097144) |
0.4 | 0.4 | GO:1990423 | RZZ complex(GO:1990423) |
0.4 | 2.5 | GO:0070876 | SOSS complex(GO:0070876) |
0.4 | 1.2 | GO:0030478 | actin cap(GO:0030478) |
0.4 | 2.5 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.4 | 3.3 | GO:0070847 | core mediator complex(GO:0070847) |
0.4 | 6.5 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.4 | 0.8 | GO:0071942 | XPC complex(GO:0071942) |
0.4 | 1.2 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.4 | 2.0 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.4 | 4.0 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.4 | 19.7 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.4 | 3.9 | GO:0042382 | paraspeckles(GO:0042382) |
0.4 | 12.1 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.4 | 3.5 | GO:0097060 | synaptic membrane(GO:0097060) |
0.4 | 1.5 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.4 | 2.3 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.4 | 6.9 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.4 | 3.4 | GO:0070552 | BRISC complex(GO:0070552) |
0.4 | 1.1 | GO:0071797 | LUBAC complex(GO:0071797) |
0.4 | 5.3 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.4 | 7.9 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.4 | 77.0 | GO:0045202 | synapse(GO:0045202) |
0.4 | 5.5 | GO:0000974 | Prp19 complex(GO:0000974) |
0.4 | 2.6 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.4 | 2.1 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.4 | 29.3 | GO:0005814 | centriole(GO:0005814) |
0.4 | 3.9 | GO:0016272 | prefoldin complex(GO:0016272) |
0.3 | 1.4 | GO:1990393 | 3M complex(GO:1990393) |
0.3 | 1.7 | GO:0034705 | potassium channel complex(GO:0034705) |
0.3 | 9.3 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.3 | 4.8 | GO:0030904 | retromer complex(GO:0030904) |
0.3 | 1.0 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.3 | 6.0 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.3 | 0.9 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.3 | 3.4 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.3 | 3.4 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.3 | 1.8 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.3 | 6.9 | GO:0031201 | SNARE complex(GO:0031201) |
0.3 | 1.5 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.3 | 87.7 | GO:0005874 | microtubule(GO:0005874) |
0.3 | 3.8 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.3 | 1.2 | GO:0032021 | NELF complex(GO:0032021) |
0.3 | 3.5 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.3 | 0.9 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.3 | 3.9 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.3 | 1.6 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.3 | 0.8 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
0.3 | 2.7 | GO:0061574 | ASAP complex(GO:0061574) |
0.3 | 27.0 | GO:0005875 | microtubule associated complex(GO:0005875) |
0.3 | 2.1 | GO:0042587 | glycogen granule(GO:0042587) |
0.3 | 1.3 | GO:0031166 | integral component of vacuolar membrane(GO:0031166) intrinsic component of vacuolar membrane(GO:0031310) |
0.3 | 1.3 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.3 | 4.9 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.3 | 0.3 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.3 | 1.8 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.3 | 1.8 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
0.3 | 1.3 | GO:0005686 | U2 snRNP(GO:0005686) |
0.2 | 2.2 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.2 | 4.4 | GO:0043679 | axon terminus(GO:0043679) |
0.2 | 0.7 | GO:0000811 | GINS complex(GO:0000811) |
0.2 | 1.2 | GO:0030315 | T-tubule(GO:0030315) |
0.2 | 1.4 | GO:0034464 | BBSome(GO:0034464) |
0.2 | 0.9 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.2 | 4.4 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.2 | 0.9 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.2 | 10.9 | GO:0005776 | autophagosome(GO:0005776) |
0.2 | 0.5 | GO:1990037 | Lewy body core(GO:1990037) |
0.2 | 1.6 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.2 | 0.2 | GO:1902636 | kinociliary basal body(GO:1902636) |
0.2 | 1.5 | GO:0000242 | pericentriolar material(GO:0000242) |
0.2 | 2.8 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.2 | 59.5 | GO:0043025 | neuronal cell body(GO:0043025) |
0.2 | 2.1 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.2 | 0.6 | GO:0036501 | UFD1-NPL4 complex(GO:0036501) |
0.2 | 1.2 | GO:0071547 | piP-body(GO:0071547) |
0.2 | 0.6 | GO:0034066 | RIC1-RGP1 guanyl-nucleotide exchange factor complex(GO:0034066) |
0.2 | 2.4 | GO:0060170 | ciliary membrane(GO:0060170) |
0.2 | 0.4 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.2 | 1.0 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.2 | 6.5 | GO:0016235 | aggresome(GO:0016235) |
0.2 | 1.4 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.2 | 1.5 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.2 | 2.5 | GO:0051233 | spindle midzone(GO:0051233) |
0.2 | 0.6 | GO:0031527 | filopodium membrane(GO:0031527) |
0.2 | 0.6 | GO:0000818 | nuclear MIS12/MIND complex(GO:0000818) |
0.2 | 1.9 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 0.7 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.2 | 2.4 | GO:0071010 | U2-type prespliceosome(GO:0071004) prespliceosome(GO:0071010) |
0.2 | 4.0 | GO:0030008 | TRAPP complex(GO:0030008) |
0.2 | 1.4 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.2 | 0.5 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.2 | 4.4 | GO:0032040 | small-subunit processome(GO:0032040) |
0.2 | 2.9 | GO:0010369 | chromocenter(GO:0010369) |
0.2 | 3.6 | GO:0031430 | M band(GO:0031430) |
0.2 | 0.5 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.2 | 0.3 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
0.2 | 2.5 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.2 | 4.6 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.2 | 1.1 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.2 | 13.1 | GO:0044853 | plasma membrane raft(GO:0044853) |
0.2 | 3.4 | GO:0005682 | U5 snRNP(GO:0005682) |
0.2 | 1.9 | GO:0005861 | troponin complex(GO:0005861) |
0.1 | 2.4 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 14.2 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 0.7 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.1 | 2.4 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 0.4 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.1 | 0.3 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 0.3 | GO:1904949 | ATPase complex(GO:1904949) |
0.1 | 0.9 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.1 | 0.5 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.1 | 1.2 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.1 | 1.2 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.1 | 0.7 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.1 | 0.9 | GO:0036396 | MIS complex(GO:0036396) |
0.1 | 36.5 | GO:0005813 | centrosome(GO:0005813) |
0.1 | 1.6 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 1.6 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.1 | 16.5 | GO:0043209 | myelin sheath(GO:0043209) |
0.1 | 2.4 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 1.2 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 4.0 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 11.2 | GO:0005769 | early endosome(GO:0005769) |
0.1 | 0.3 | GO:0035859 | Seh1-associated complex(GO:0035859) Iml1 complex(GO:1990130) |
0.1 | 1.7 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 0.6 | GO:0030427 | site of polarized growth(GO:0030427) |
0.1 | 0.5 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.1 | 0.2 | GO:0005687 | U4 snRNP(GO:0005687) |
0.1 | 0.6 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 604.1 | GO:0016021 | integral component of membrane(GO:0016021) |
0.1 | 0.2 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 0.6 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.1 | 0.8 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.1 | 0.4 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.1 | 0.2 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 0.3 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.1 | 0.3 | GO:0097361 | MMXD complex(GO:0071817) CIA complex(GO:0097361) |
0.1 | 1.3 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 2.6 | GO:0035861 | site of double-strand break(GO:0035861) |
0.1 | 0.3 | GO:0031513 | nonmotile primary cilium(GO:0031513) primary cilium(GO:0072372) |
0.1 | 1.2 | GO:0032155 | cell division site(GO:0032153) cell division site part(GO:0032155) |
0.1 | 0.9 | GO:0005684 | U2-type spliceosomal complex(GO:0005684) |
0.1 | 0.3 | GO:0070187 | telosome(GO:0070187) |
0.1 | 0.5 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.1 | 0.6 | GO:0048500 | signal recognition particle(GO:0048500) |
0.1 | 0.7 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.1 | 0.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 0.8 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.1 | 1.4 | GO:1902562 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.0 | 0.3 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.4 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.0 | 0.5 | GO:0042555 | MCM complex(GO:0042555) |
0.0 | 0.2 | GO:0017177 | glucosidase II complex(GO:0017177) |
0.0 | 0.4 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.0 | 0.2 | GO:0071986 | Ragulator complex(GO:0071986) |
0.0 | 0.3 | GO:0090568 | nuclear transcriptional repressor complex(GO:0090568) |
0.0 | 0.1 | GO:0044447 | axoneme part(GO:0044447) |
0.0 | 0.2 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.2 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 0.4 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 6.3 | GO:0005794 | Golgi apparatus(GO:0005794) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
13.4 | 26.7 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
12.9 | 38.6 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
10.0 | 40.0 | GO:0002153 | steroid receptor RNA activator RNA binding(GO:0002153) |
8.0 | 55.9 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
7.8 | 54.7 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
7.5 | 75.2 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
7.3 | 29.4 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
7.3 | 21.8 | GO:0016492 | G-protein coupled neurotensin receptor activity(GO:0016492) |
7.2 | 28.8 | GO:0045183 | translation factor activity, non-nucleic acid binding(GO:0045183) |
7.2 | 28.7 | GO:0031687 | A2A adenosine receptor binding(GO:0031687) |
6.5 | 26.2 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
6.4 | 19.1 | GO:0001847 | opsonin receptor activity(GO:0001847) |
6.3 | 50.6 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
6.3 | 18.8 | GO:0086057 | voltage-gated calcium channel activity involved in bundle of His cell action potential(GO:0086057) |
5.8 | 17.4 | GO:0004615 | phosphomannomutase activity(GO:0004615) |
5.8 | 57.7 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
5.7 | 34.4 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
5.7 | 34.1 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
5.6 | 22.2 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
5.5 | 21.9 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
5.5 | 32.8 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
5.2 | 20.9 | GO:0033883 | pyridoxal phosphatase activity(GO:0033883) |
5.1 | 30.8 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
5.1 | 25.6 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
5.0 | 30.0 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
4.9 | 19.5 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
4.9 | 97.5 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
4.8 | 159.1 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
4.8 | 24.0 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
4.5 | 22.7 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
4.4 | 13.2 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
4.4 | 17.4 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
4.3 | 21.6 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
4.3 | 17.2 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
4.3 | 42.8 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
4.3 | 25.6 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
4.2 | 29.4 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
4.1 | 16.6 | GO:0038025 | reelin receptor activity(GO:0038025) |
4.0 | 28.3 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
4.0 | 12.1 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
4.0 | 12.1 | GO:0031798 | type 1 metabotropic glutamate receptor binding(GO:0031798) |
3.9 | 39.5 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
3.9 | 19.5 | GO:0097001 | ceramide binding(GO:0097001) |
3.7 | 18.7 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
3.7 | 181.2 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
3.6 | 21.8 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
3.6 | 10.9 | GO:0010428 | methyl-CpNpG binding(GO:0010428) |
3.6 | 21.5 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
3.5 | 28.2 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
3.5 | 21.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
3.5 | 42.0 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
3.5 | 10.5 | GO:0035939 | microsatellite binding(GO:0035939) |
3.5 | 13.9 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
3.4 | 20.7 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
3.4 | 23.5 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
3.3 | 16.7 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
3.3 | 23.0 | GO:0031812 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
3.3 | 45.5 | GO:0070097 | delta-catenin binding(GO:0070097) |
3.2 | 28.9 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
3.1 | 3.1 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
3.1 | 27.9 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
3.1 | 9.3 | GO:0019002 | GMP binding(GO:0019002) |
3.1 | 12.4 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) |
3.1 | 30.7 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
3.1 | 24.5 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
3.0 | 21.2 | GO:0004969 | histamine receptor activity(GO:0004969) |
3.0 | 21.1 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
3.0 | 21.0 | GO:0000298 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) |
3.0 | 75.0 | GO:0031402 | sodium ion binding(GO:0031402) |
3.0 | 17.7 | GO:0004359 | glutaminase activity(GO:0004359) |
2.9 | 8.8 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
2.9 | 214.3 | GO:0001540 | beta-amyloid binding(GO:0001540) |
2.8 | 19.9 | GO:0097016 | L27 domain binding(GO:0097016) |
2.8 | 33.9 | GO:0032051 | clathrin light chain binding(GO:0032051) |
2.8 | 13.9 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
2.7 | 24.4 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
2.6 | 7.9 | GO:0016015 | morphogen activity(GO:0016015) |
2.6 | 7.9 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
2.6 | 29.0 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
2.5 | 12.7 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
2.5 | 151.3 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
2.5 | 27.3 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
2.5 | 14.8 | GO:0048495 | Roundabout binding(GO:0048495) |
2.5 | 14.8 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
2.5 | 24.7 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
2.5 | 24.5 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
2.4 | 19.5 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
2.4 | 67.1 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
2.3 | 18.7 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
2.3 | 201.4 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
2.3 | 9.3 | GO:0072591 | citrate-L-glutamate ligase activity(GO:0072591) |
2.3 | 6.9 | GO:0051424 | corticotropin-releasing hormone binding(GO:0051424) |
2.3 | 38.7 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
2.2 | 22.4 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
2.2 | 11.2 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
2.2 | 8.9 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
2.2 | 15.3 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
2.2 | 8.7 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
2.2 | 12.9 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
2.1 | 32.2 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
2.1 | 8.5 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
2.1 | 8.3 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
2.1 | 12.4 | GO:0000828 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
2.1 | 12.4 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
2.1 | 129.4 | GO:0046875 | ephrin receptor binding(GO:0046875) |
2.0 | 6.1 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
2.0 | 6.1 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
2.0 | 14.0 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
2.0 | 49.1 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
2.0 | 15.6 | GO:0019992 | diacylglycerol binding(GO:0019992) |
1.9 | 5.8 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
1.9 | 9.7 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
1.9 | 3.9 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
1.9 | 5.8 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
1.9 | 45.9 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
1.9 | 1.9 | GO:0072590 | N-acetyl-L-aspartate-L-glutamate ligase activity(GO:0072590) |
1.9 | 5.7 | GO:0031692 | alpha-1A adrenergic receptor binding(GO:0031691) alpha-1B adrenergic receptor binding(GO:0031692) follicle-stimulating hormone receptor binding(GO:0031762) V2 vasopressin receptor binding(GO:0031896) |
1.8 | 14.7 | GO:0005042 | netrin receptor activity(GO:0005042) |
1.8 | 5.5 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
1.8 | 5.4 | GO:1990763 | arrestin family protein binding(GO:1990763) |
1.8 | 3.6 | GO:0008520 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
1.8 | 24.9 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
1.8 | 7.1 | GO:1902379 | chemoattractant activity involved in axon guidance(GO:1902379) |
1.8 | 12.4 | GO:0030955 | potassium ion binding(GO:0030955) |
1.8 | 22.8 | GO:0042043 | neurexin family protein binding(GO:0042043) |
1.7 | 10.5 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
1.7 | 10.4 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
1.7 | 136.9 | GO:0030276 | clathrin binding(GO:0030276) |
1.7 | 15.4 | GO:0031849 | olfactory receptor binding(GO:0031849) |
1.7 | 119.1 | GO:0035254 | glutamate receptor binding(GO:0035254) |
1.7 | 13.5 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
1.7 | 28.6 | GO:0005522 | profilin binding(GO:0005522) |
1.7 | 8.4 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
1.7 | 5.0 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
1.6 | 4.9 | GO:0070052 | collagen V binding(GO:0070052) |
1.6 | 31.2 | GO:0015643 | toxic substance binding(GO:0015643) |
1.6 | 11.4 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
1.6 | 22.7 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
1.6 | 4.8 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
1.6 | 8.0 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
1.6 | 15.9 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
1.6 | 4.7 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
1.6 | 11.0 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
1.6 | 9.4 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
1.6 | 4.7 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
1.5 | 4.6 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
1.5 | 20.1 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
1.5 | 3.1 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
1.5 | 1.5 | GO:0031208 | POZ domain binding(GO:0031208) |
1.5 | 12.1 | GO:0032184 | SUMO polymer binding(GO:0032184) |
1.5 | 37.6 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
1.5 | 16.5 | GO:0036310 | annealing helicase activity(GO:0036310) |
1.5 | 6.0 | GO:0035276 | ethanol binding(GO:0035276) |
1.5 | 4.5 | GO:0001888 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) |
1.5 | 7.4 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
1.5 | 10.4 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
1.5 | 54.6 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
1.5 | 7.3 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
1.4 | 2.9 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
1.4 | 72.0 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
1.4 | 7.2 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
1.4 | 2.9 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
1.4 | 14.1 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
1.4 | 7.0 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
1.4 | 114.4 | GO:0048365 | Rac GTPase binding(GO:0048365) |
1.4 | 9.7 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
1.4 | 8.3 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
1.4 | 4.1 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
1.4 | 27.3 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
1.4 | 1.4 | GO:0005330 | dopamine:sodium symporter activity(GO:0005330) |
1.4 | 20.3 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
1.4 | 6.8 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
1.3 | 58.0 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
1.3 | 6.7 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
1.3 | 4.0 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
1.3 | 8.0 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
1.3 | 5.2 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
1.3 | 10.4 | GO:1903136 | cuprous ion binding(GO:1903136) |
1.3 | 9.1 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
1.3 | 19.4 | GO:0031996 | thioesterase binding(GO:0031996) |
1.3 | 5.1 | GO:0033142 | progesterone receptor binding(GO:0033142) |
1.3 | 12.7 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
1.3 | 6.3 | GO:1990188 | euchromatin binding(GO:1990188) |
1.3 | 5.0 | GO:0043559 | insulin binding(GO:0043559) |
1.2 | 3.7 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
1.2 | 13.6 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
1.2 | 3.7 | GO:0052895 | norspermine:oxygen oxidoreductase activity(GO:0052894) N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity(GO:0052895) |
1.2 | 79.4 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
1.2 | 3.6 | GO:0017084 | glutamate 5-kinase activity(GO:0004349) glutamate-5-semialdehyde dehydrogenase activity(GO:0004350) delta1-pyrroline-5-carboxylate synthetase activity(GO:0017084) amino acid kinase activity(GO:0019202) |
1.2 | 24.9 | GO:0005523 | tropomyosin binding(GO:0005523) |
1.2 | 10.6 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
1.2 | 8.3 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
1.2 | 5.9 | GO:0004985 | opioid receptor activity(GO:0004985) |
1.2 | 79.6 | GO:0019894 | kinesin binding(GO:0019894) |
1.2 | 19.6 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
1.2 | 5.8 | GO:0004111 | creatine kinase activity(GO:0004111) |
1.1 | 4.5 | GO:0003883 | CTP synthase activity(GO:0003883) |
1.1 | 3.4 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
1.1 | 7.9 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
1.1 | 3.3 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
1.1 | 2.2 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
1.1 | 4.4 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
1.1 | 4.4 | GO:0099609 | microtubule lateral binding(GO:0099609) |
1.1 | 3.3 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
1.1 | 13.0 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
1.1 | 8.6 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
1.1 | 25.8 | GO:0031005 | filamin binding(GO:0031005) |
1.1 | 7.5 | GO:0031013 | troponin I binding(GO:0031013) |
1.1 | 86.6 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
1.1 | 1.1 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
1.1 | 2.1 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
1.1 | 17.9 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
1.0 | 38.5 | GO:0030507 | spectrin binding(GO:0030507) |
1.0 | 19.7 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
1.0 | 5.2 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
1.0 | 1.0 | GO:0008988 | rRNA (adenine-N6-)-methyltransferase activity(GO:0008988) |
1.0 | 4.1 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
1.0 | 3.1 | GO:0035516 | oxidative DNA demethylase activity(GO:0035516) RNA N6-methyladenosine dioxygenase activity(GO:1990931) |
1.0 | 11.0 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) |
1.0 | 17.9 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
1.0 | 3.0 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
1.0 | 9.9 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
1.0 | 2.9 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
1.0 | 2.9 | GO:0051425 | PTB domain binding(GO:0051425) |
1.0 | 22.3 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
1.0 | 1.0 | GO:0019948 | SUMO activating enzyme activity(GO:0019948) |
1.0 | 5.8 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
1.0 | 83.4 | GO:0000149 | SNARE binding(GO:0000149) |
1.0 | 10.5 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.9 | 8.5 | GO:0042285 | xylosyltransferase activity(GO:0042285) |
0.9 | 3.8 | GO:0004096 | catalase activity(GO:0004096) |
0.9 | 3.7 | GO:0034597 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
0.9 | 2.8 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.9 | 24.0 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.9 | 11.9 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.9 | 2.7 | GO:0004379 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
0.9 | 0.9 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.9 | 4.5 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) cAMP-dependent protein kinase activity(GO:0004691) |
0.9 | 7.2 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.9 | 12.5 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.9 | 31.3 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.9 | 6.2 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.9 | 34.7 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.9 | 3.5 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.9 | 5.2 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.9 | 2.6 | GO:0004155 | 6,7-dihydropteridine reductase activity(GO:0004155) |
0.9 | 2.6 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
0.9 | 1.7 | GO:0001729 | ceramide kinase activity(GO:0001729) |
0.9 | 17.1 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.9 | 3.4 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.8 | 6.8 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.8 | 4.2 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.8 | 3.4 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.8 | 2.5 | GO:0004962 | endothelin receptor activity(GO:0004962) |
0.8 | 10.0 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.8 | 16.6 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.8 | 3.3 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
0.8 | 4.1 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
0.8 | 12.3 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.8 | 11.4 | GO:0051378 | serotonin binding(GO:0051378) |
0.8 | 4.8 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.8 | 3.2 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.8 | 20.7 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.8 | 1.6 | GO:0036004 | GAF domain binding(GO:0036004) |
0.8 | 0.8 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.8 | 25.9 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.8 | 10.1 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.8 | 13.9 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.8 | 1.5 | GO:0032135 | DNA insertion or deletion binding(GO:0032135) single base insertion or deletion binding(GO:0032138) |
0.8 | 104.0 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.8 | 2.3 | GO:0004968 | gonadotropin-releasing hormone receptor activity(GO:0004968) |
0.8 | 10.7 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.8 | 15.1 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
0.8 | 7.5 | GO:0033691 | sialic acid binding(GO:0033691) |
0.7 | 11.9 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.7 | 30.5 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.7 | 23.7 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.7 | 5.1 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.7 | 0.7 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.7 | 5.1 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
0.7 | 3.6 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.7 | 7.1 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.7 | 16.3 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.7 | 6.4 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.7 | 48.1 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.7 | 2.8 | GO:0004816 | asparagine-tRNA ligase activity(GO:0004816) |
0.7 | 4.9 | GO:0015616 | DNA translocase activity(GO:0015616) |
0.7 | 10.5 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.7 | 0.7 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.7 | 17.3 | GO:0031489 | myosin V binding(GO:0031489) |
0.7 | 3.4 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.7 | 2.1 | GO:0042806 | fucose binding(GO:0042806) |
0.7 | 1.4 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.7 | 159.9 | GO:0008017 | microtubule binding(GO:0008017) |
0.7 | 2.0 | GO:0004798 | thymidylate kinase activity(GO:0004798) |
0.7 | 2.0 | GO:0071820 | N-box binding(GO:0071820) |
0.7 | 12.1 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.7 | 0.7 | GO:0045142 | triplex DNA binding(GO:0045142) |
0.7 | 2.7 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.7 | 4.0 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.7 | 4.0 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.7 | 21.1 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.7 | 0.7 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.7 | 13.0 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.6 | 0.6 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.6 | 29.7 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.6 | 2.6 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.6 | 1.9 | GO:0097604 | temperature-gated cation channel activity(GO:0097604) mechanically-gated potassium channel activity(GO:0098782) |
0.6 | 1.3 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.6 | 3.8 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.6 | 2.5 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.6 | 34.9 | GO:0015631 | tubulin binding(GO:0015631) |
0.6 | 1.8 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.6 | 4.9 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.6 | 1.8 | GO:0004637 | phosphoribosylamine-glycine ligase activity(GO:0004637) |
0.6 | 3.0 | GO:2001069 | glycogen binding(GO:2001069) |
0.6 | 7.2 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.6 | 5.4 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.6 | 1.8 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.6 | 1.2 | GO:0030629 | U6 snRNA 3'-end binding(GO:0030629) |
0.6 | 3.6 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.6 | 12.4 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.6 | 1.8 | GO:0005457 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
0.6 | 39.8 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.6 | 14.1 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.6 | 7.0 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.6 | 15.7 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.6 | 6.4 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.6 | 16.1 | GO:0030546 | receptor activator activity(GO:0030546) |
0.6 | 2.9 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.6 | 1.7 | GO:0030298 | receptor signaling protein tyrosine kinase activator activity(GO:0030298) |
0.6 | 6.7 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.6 | 32.3 | GO:0022839 | ion gated channel activity(GO:0022839) |
0.6 | 2.8 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.5 | 2.2 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.5 | 2.2 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.5 | 18.6 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.5 | 2.7 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.5 | 7.1 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.5 | 4.4 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.5 | 10.3 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.5 | 5.9 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.5 | 197.1 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.5 | 2.1 | GO:0097643 | amylin receptor activity(GO:0097643) |
0.5 | 1.1 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.5 | 4.2 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.5 | 8.3 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.5 | 6.2 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.5 | 1.5 | GO:0001160 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
0.5 | 3.5 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.5 | 3.5 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.5 | 14.0 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.5 | 2.0 | GO:0004161 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
0.5 | 1.5 | GO:0016213 | linoleoyl-CoA desaturase activity(GO:0016213) |
0.5 | 6.4 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.5 | 1.5 | GO:0030622 | U4atac snRNA binding(GO:0030622) |
0.5 | 2.0 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.5 | 1.0 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.5 | 4.4 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.5 | 12.7 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.5 | 1.4 | GO:0003920 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
0.5 | 2.4 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.5 | 5.2 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.5 | 7.6 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.5 | 32.6 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.5 | 0.9 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.5 | 32.0 | GO:0044325 | ion channel binding(GO:0044325) |
0.5 | 1.4 | GO:0050294 | alcohol sulfotransferase activity(GO:0004027) steroid sulfotransferase activity(GO:0050294) |
0.5 | 1.4 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
0.5 | 0.9 | GO:0097677 | STAT family protein binding(GO:0097677) |
0.4 | 1.8 | GO:0071796 | K6-linked polyubiquitin binding(GO:0071796) |
0.4 | 2.7 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.4 | 1.3 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.4 | 1.3 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.4 | 1.8 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
0.4 | 3.1 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.4 | 5.7 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.4 | 3.5 | GO:0052655 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.4 | 0.9 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.4 | 3.0 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.4 | 1.3 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.4 | 38.2 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.4 | 1.3 | GO:0047291 | lactosylceramide alpha-2,3-sialyltransferase activity(GO:0047291) |
0.4 | 0.9 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.4 | 2.6 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
0.4 | 2.6 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.4 | 1.3 | GO:0047598 | sterol delta7 reductase activity(GO:0009918) 7-dehydrocholesterol reductase activity(GO:0047598) |
0.4 | 4.7 | GO:0008061 | chitin binding(GO:0008061) |
0.4 | 7.6 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.4 | 1.3 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
0.4 | 1.7 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.4 | 2.9 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.4 | 1.2 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
0.4 | 2.5 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.4 | 7.4 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.4 | 1.6 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.4 | 0.4 | GO:0001083 | transcription factor activity, RNA polymerase II basal transcription factor binding(GO:0001083) |
0.4 | 2.4 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
0.4 | 2.8 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
0.4 | 4.0 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.4 | 1.9 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.4 | 1.9 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.4 | 1.5 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.4 | 3.8 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.4 | 1.5 | GO:0008493 | tetracycline transporter activity(GO:0008493) |
0.4 | 3.0 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.4 | 1.9 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.4 | 0.7 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.4 | 1.5 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
0.4 | 1.5 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.4 | 3.6 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.4 | 1.8 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.4 | 1.4 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.3 | 1.4 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
0.3 | 3.8 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.3 | 1.0 | GO:0003896 | DNA primase activity(GO:0003896) |
0.3 | 1.0 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
0.3 | 3.1 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.3 | 6.5 | GO:0030551 | cyclic nucleotide binding(GO:0030551) |
0.3 | 1.0 | GO:0004421 | hydroxymethylglutaryl-CoA synthase activity(GO:0004421) |
0.3 | 2.7 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.3 | 2.0 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
0.3 | 2.0 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.3 | 3.6 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.3 | 0.6 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
0.3 | 1.0 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.3 | 2.5 | GO:0000150 | recombinase activity(GO:0000150) |
0.3 | 16.2 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.3 | 0.9 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.3 | 0.9 | GO:0046969 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
0.3 | 36.0 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.3 | 1.2 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.3 | 13.6 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.3 | 1.5 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.3 | 1.5 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.3 | 0.6 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
0.3 | 0.9 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.3 | 1.4 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.3 | 1.7 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.3 | 174.9 | GO:0005509 | calcium ion binding(GO:0005509) |
0.3 | 2.0 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.3 | 2.8 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.3 | 8.8 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.3 | 0.8 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
0.3 | 10.7 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.3 | 2.7 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.3 | 2.4 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.3 | 0.8 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
0.3 | 4.7 | GO:0016247 | channel regulator activity(GO:0016247) |
0.3 | 0.8 | GO:0043199 | sulfate binding(GO:0043199) |
0.3 | 3.6 | GO:0043047 | single-stranded telomeric DNA binding(GO:0043047) |
0.3 | 6.7 | GO:0017022 | myosin binding(GO:0017022) |
0.3 | 0.3 | GO:0004819 | glutamine-tRNA ligase activity(GO:0004819) |
0.3 | 2.0 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.3 | 7.8 | GO:0005109 | frizzled binding(GO:0005109) |
0.2 | 3.8 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.2 | 1.2 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.2 | 0.9 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) ornithine decarboxylase regulator activity(GO:0042979) |
0.2 | 8.0 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.2 | 6.8 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
0.2 | 0.9 | GO:0030911 | TPR domain binding(GO:0030911) |
0.2 | 0.7 | GO:0004512 | inositol-3-phosphate synthase activity(GO:0004512) intramolecular lyase activity(GO:0016872) |
0.2 | 0.7 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.2 | 0.7 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
0.2 | 3.0 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.2 | 1.3 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.2 | 1.1 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.2 | 3.5 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
0.2 | 0.8 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.2 | 4.5 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.2 | 1.0 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.2 | 1.0 | GO:0080084 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) 5S rDNA binding(GO:0080084) |
0.2 | 0.6 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.2 | 1.2 | GO:0050733 | RS domain binding(GO:0050733) |
0.2 | 1.4 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.2 | 0.8 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.2 | 7.0 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.2 | 0.8 | GO:0032093 | SAM domain binding(GO:0032093) |
0.2 | 2.3 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.2 | 1.1 | GO:0043398 | HLH domain binding(GO:0043398) SUMO conjugating enzyme activity(GO:0061656) |
0.2 | 1.5 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.2 | 44.1 | GO:0003924 | GTPase activity(GO:0003924) |
0.2 | 2.6 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.2 | 0.2 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.2 | 0.7 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
0.2 | 0.6 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.2 | 0.2 | GO:0015172 | acidic amino acid transmembrane transporter activity(GO:0015172) |
0.2 | 1.3 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.2 | 2.0 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.2 | 4.7 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.2 | 0.7 | GO:0045545 | syndecan binding(GO:0045545) |
0.2 | 3.3 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 1.4 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.2 | 1.7 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.2 | 0.3 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.2 | 0.6 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.2 | 3.7 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.2 | 0.8 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.2 | 2.8 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.2 | 6.1 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.2 | 0.5 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.2 | 0.2 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.1 | 0.6 | GO:0008199 | ferric iron binding(GO:0008199) |
0.1 | 0.7 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.1 | 0.3 | GO:0008263 | pyrimidine-specific mismatch base pair DNA N-glycosylase activity(GO:0008263) |
0.1 | 0.4 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.1 | 0.7 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.1 | 2.9 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.1 | 1.1 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.1 | 3.0 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 0.7 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 0.8 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.1 | 4.4 | GO:0070330 | aromatase activity(GO:0070330) |
0.1 | 2.3 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 14.3 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 0.5 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.1 | 0.7 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 0.8 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 0.3 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
0.1 | 2.7 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.1 | 1.7 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.1 | 0.4 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.1 | 0.3 | GO:0031370 | eukaryotic initiation factor 4G binding(GO:0031370) |
0.1 | 4.4 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.1 | 5.3 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.1 | 0.9 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 0.4 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.1 | 0.5 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
0.1 | 10.9 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 1.0 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 1.2 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.1 | 1.2 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 0.5 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.1 | 0.3 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 2.4 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.1 | 0.2 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 0.6 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.1 | 2.3 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.1 | 0.1 | GO:0098770 | FBXO family protein binding(GO:0098770) |
0.1 | 0.5 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.1 | 0.1 | GO:0000700 | mismatch base pair DNA N-glycosylase activity(GO:0000700) |
0.1 | 0.4 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.1 | 2.4 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.1 | 0.1 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.1 | 0.4 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 0.4 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.1 | 0.3 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.3 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.2 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.1 | 0.2 | GO:0004958 | prostaglandin F receptor activity(GO:0004958) |
0.1 | 0.4 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.1 | 0.2 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 2.4 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.1 | 0.4 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.1 | 30.9 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.1 | 0.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.1 | 0.1 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.0 | 4.1 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 0.4 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.0 | 0.1 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.0 | 0.3 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.0 | 0.1 | GO:0070773 | protein-N-terminal glutamine amidohydrolase activity(GO:0070773) |
0.0 | 0.9 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.0 | 0.1 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
0.0 | 0.1 | GO:0033858 | N-acetylgalactosamine kinase activity(GO:0033858) |
0.0 | 0.4 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.0 | 0.1 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
0.0 | 0.2 | GO:0043426 | MRF binding(GO:0043426) |
0.0 | 0.1 | GO:0008176 | tRNA (guanine-N7-)-methyltransferase activity(GO:0008176) |
0.0 | 0.1 | GO:0034603 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.0 | 0.6 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.0 | 0.7 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.0 | 0.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.0 | 0.1 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.0 | 0.1 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.0 | 0.2 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
0.0 | 0.1 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.0 | 0.2 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.0 | 0.1 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.0 | 0.0 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
0.0 | 0.1 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.0 | 0.2 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.0 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.7 | 122.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
2.4 | 53.1 | PID S1P S1P4 PATHWAY | S1P4 pathway |
2.2 | 125.7 | PID RAS PATHWAY | Regulation of Ras family activation |
1.8 | 7.1 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
1.7 | 55.1 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
1.7 | 76.1 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
1.5 | 3.1 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
1.5 | 7.6 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
1.4 | 82.8 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
1.4 | 83.9 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
1.4 | 49.6 | ST GA12 PATHWAY | G alpha 12 Pathway |
1.3 | 122.7 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
1.3 | 46.4 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
1.3 | 37.8 | PID REELIN PATHWAY | Reelin signaling pathway |
1.2 | 76.1 | PID LKB1 PATHWAY | LKB1 signaling events |
1.2 | 70.1 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
1.1 | 28.6 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
1.1 | 26.3 | PID ARF 3PATHWAY | Arf1 pathway |
1.0 | 68.4 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
1.0 | 2.0 | PID EPO PATHWAY | EPO signaling pathway |
1.0 | 3.0 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
1.0 | 2.9 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.9 | 12.0 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.9 | 15.1 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.8 | 37.1 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.8 | 21.6 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.8 | 3.0 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.7 | 13.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.7 | 40.9 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.7 | 21.2 | PID CDC42 PATHWAY | CDC42 signaling events |
0.7 | 8.1 | ST STAT3 PATHWAY | STAT3 Pathway |
0.7 | 18.8 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.7 | 4.6 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.7 | 3.3 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.6 | 9.7 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.6 | 5.1 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.6 | 18.6 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.6 | 23.6 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.6 | 24.1 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.5 | 0.5 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.5 | 11.3 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.5 | 3.5 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.5 | 14.4 | PID AURORA A PATHWAY | Aurora A signaling |
0.5 | 10.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.5 | 4.1 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.5 | 2.3 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.4 | 2.7 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.4 | 6.6 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.4 | 31.1 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.4 | 26.7 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.4 | 0.9 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.4 | 8.5 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.4 | 9.7 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.4 | 4.2 | PID IGF1 PATHWAY | IGF1 pathway |
0.4 | 3.3 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.4 | 2.8 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.4 | 10.7 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.4 | 4.3 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.4 | 5.1 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.4 | 1.8 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.4 | 22.8 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.3 | 2.8 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.3 | 7.5 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.3 | 15.2 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.3 | 12.5 | PID ATR PATHWAY | ATR signaling pathway |
0.3 | 1.8 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.3 | 0.8 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.2 | 7.5 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.2 | 47.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.2 | 0.7 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.2 | 45.3 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.2 | 4.4 | PID SHP2 PATHWAY | SHP2 signaling |
0.2 | 2.3 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.2 | 2.6 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.2 | 1.5 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.2 | 1.6 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 2.7 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 4.4 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 4.0 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 0.8 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 1.6 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 2.2 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 2.7 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 0.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 2.2 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 0.4 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 2.3 | PID ATM PATHWAY | ATM pathway |
0.1 | 2.7 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 0.2 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.1 | 0.3 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 0.7 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 0.5 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.7 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.9 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 5.2 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.4 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 4.8 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.8 | 149.4 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
6.0 | 102.2 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
5.1 | 61.6 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
4.9 | 255.9 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
4.2 | 137.6 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
3.9 | 50.1 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
3.4 | 86.1 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
3.3 | 52.5 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
3.0 | 182.0 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
3.0 | 39.3 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
3.0 | 122.7 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
2.9 | 69.6 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
2.5 | 2.5 | REACTOME OPIOID SIGNALLING | Genes involved in Opioid Signalling |
2.5 | 52.5 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
2.5 | 44.1 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
2.4 | 9.6 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
2.1 | 34.2 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
2.1 | 70.5 | REACTOME KINESINS | Genes involved in Kinesins |
2.1 | 2.1 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
2.1 | 90.5 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
2.0 | 14.2 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
2.0 | 43.4 | REACTOME GABA B RECEPTOR ACTIVATION | Genes involved in GABA B receptor activation |
1.9 | 39.0 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
1.8 | 36.3 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
1.8 | 82.4 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
1.7 | 22.4 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
1.7 | 11.7 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
1.6 | 45.6 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
1.5 | 18.3 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
1.5 | 24.1 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
1.5 | 40.2 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
1.4 | 32.2 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
1.4 | 20.6 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
1.4 | 55.7 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
1.3 | 5.4 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
1.3 | 6.5 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
1.3 | 25.9 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
1.3 | 45.9 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
1.3 | 28.8 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
1.2 | 10.6 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
1.1 | 1.1 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
1.1 | 8.9 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
1.1 | 22.6 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
1.1 | 47.0 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
1.0 | 16.5 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.9 | 4.6 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.9 | 29.3 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.9 | 13.7 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.9 | 55.2 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.9 | 7.8 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.9 | 73.5 | REACTOME NEURONAL SYSTEM | Genes involved in Neuronal System |
0.8 | 8.5 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.8 | 14.2 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.8 | 18.4 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.7 | 37.4 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.7 | 15.4 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.7 | 39.7 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.7 | 7.7 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.7 | 23.9 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.7 | 72.4 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.6 | 13.0 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.6 | 14.9 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.6 | 4.3 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.6 | 48.5 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
0.6 | 77.1 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.6 | 1.1 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.5 | 23.3 | REACTOME PI METABOLISM | Genes involved in PI Metabolism |
0.5 | 9.4 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.5 | 86.3 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.5 | 10.1 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.5 | 5.3 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.5 | 11.1 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.5 | 4.3 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.5 | 44.1 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.5 | 10.1 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.4 | 23.8 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.4 | 12.1 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.4 | 15.1 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.4 | 14.4 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.4 | 19.7 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.4 | 16.8 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.4 | 10.0 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.4 | 9.5 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.4 | 2.7 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.4 | 5.6 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.4 | 3.7 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.4 | 6.3 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
0.4 | 8.0 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.4 | 1.8 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.3 | 5.9 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.3 | 11.7 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.3 | 1.0 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.3 | 6.3 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.3 | 4.7 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.3 | 10.0 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.3 | 3.0 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.3 | 4.9 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.3 | 3.2 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.3 | 2.9 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.3 | 5.7 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.3 | 2.8 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.2 | 9.7 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
0.2 | 4.3 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.2 | 0.2 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.2 | 1.0 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.2 | 6.5 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.2 | 2.9 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.2 | 2.9 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.2 | 3.5 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.2 | 0.7 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.2 | 3.4 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.2 | 13.6 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
0.2 | 2.0 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.1 | 1.6 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 5.7 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.1 | 2.2 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.1 | 7.8 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.1 | 4.2 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 2.1 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 10.8 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.1 | 3.3 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.1 | 1.3 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 5.0 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 1.9 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 0.9 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.1 | 0.9 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 1.6 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 1.6 | REACTOME E2F MEDIATED REGULATION OF DNA REPLICATION | Genes involved in E2F mediated regulation of DNA replication |
0.1 | 0.9 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 0.6 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.1 | 0.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 0.8 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.1 | 1.0 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.1 | 1.2 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.1 | 7.9 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 1.4 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 0.2 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 0.6 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.1 | 0.5 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 1.3 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 1.0 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 0.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.3 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.0 | 0.7 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.0 | 0.5 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.5 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.0 | 0.3 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.0 | 0.1 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 0.7 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |